cephalosporin c has been researched along with Blood Poisoning in 387 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 200 (51.68) | 18.7374 |
1990's | 66 (17.05) | 18.2507 |
2000's | 50 (12.92) | 29.6817 |
2010's | 44 (11.37) | 24.3611 |
2020's | 27 (6.98) | 2.80 |
Authors | Studies |
---|---|
GEDDES, AM; MURDOCH, JM; SPEIRS, CF; WALLACE, ET | 1 |
Chatfield, MD; Donaldson, A; Harris, PNA; Harris-Brown, T; Henderson, A; Lye, D; Paterson, DL; Wright, H | 1 |
Akselsen, AB; Sheth, CC; Veses, V | 1 |
Barnini, S; Della Sala, L; Falcone, M; Farcomeni, A; Leonildi, A; Menichetti, F; Tiseo, G; Vecchione, A | 1 |
Kovacs, D; Matthews, L; Msanga, DR; Mshana, SE; Oravcova, K; Seni, J; Silago, V | 1 |
Jia, P; Jia, X; Kang, M; Li, R; Li, X; Liu, X; Xu, Y; Yang, Q; Yu, W; Zhu, Y | 1 |
Chen, PY; Dong, QY; Gong, XY; He, XR; Hu, JT; Li, W; Wang, T; Yang, YH; Yu, YQ | 1 |
Bakali, W; Bilima, S; Denis, B; Feasey, NA; Gordon, SB; Jewell, CP; Kawaza, K; Lalloo, DG; Langton, J; Lester, R; Mallewa, J; Mango, J; Mangochi, H; Musicha, P; Pearse, O | 1 |
Liu, S; Lopes, B; Patil, S; Wagh, K; Wen, F | 1 |
Barchia, I; Karmila, A; Ramandati, A; Zhang, L | 1 |
Bartoletti, M; Bassetti, M; Bavaro, DF; Bono, VD; Buonomo, AR; Canta, F; Carbonara, S; Congera, P; Corcione, S; De Rosa, FG; Durante-Mangoni, E; Falcone, M; Gentile, I; Giacobbe, DR; Karruli, A; Maraolo, AE; Mikulska, MK; Moriello, NS; Palmiero, G; Paradiso, L; Sordella, F; Tascini, C; Tiseo, G; Vena, A; Viale, P; Vozza, A | 1 |
Abbey, L; Abdelghany, TM; Abdellatif, MH; Abdelmohsen, UR; Abduljaleel Alzawar, NS; Abid, MF; Abu Kasim, AFB; Abu Saad, H; Adolpho, LF; Agostini, F; Agrizii, AP; Ahmed, S; Akce, M; Åkesson, D; Al-Awaadh, AM; Al-Mutar, DMK; Al-Odayni, AB; Al-Rajhi, AMH; Alaaeldin, R; Alam, M; Alam, MM; Alanazi, MA; Alattar, H; Alawlaqi, MM; Aldebis, HK; Algehainy, NA; Almeida, AA; Aloisi, F; Alrahlah, A; Alsenani, F; Alshabib, A; Altemani, FH; Althagafi, A; Amari, A; Andronesi, AG; Antonyuk, M; Arantes, TD; Araújo, R; Arrotti, S; Asakura, T; Asib, N; Atlaskin, AA; Aung, MS; Axiaq, A; Azekawa, S; Bacon, S; Bagalagel, A; Balbinot, GS; Barnet, LS; Baroyi, SAHM; Barreto, F; Barth, Y; Barysheva, AV; Bassa, E; Basu, R; Basu, S; Bates, C; Bautista, LS; Beitl, K; Beloti, MM; Benatti, G; Benavent-Celma, C; Bentaher, A; Bergsland, N; Bernardino, AF; Bernhardt, A; Bhandari, RK; Bhaskaran, K; Bhate, K; Bhattacharjee, A; Bian, X; Bien, EM; Birch, M; Bishara, K; Biswas, JP; Bleha, R; Bocale, R; Bona, S; Boriani, G; Bouyssi, A; Bradley, D; Bravo-Sánchez, MG; Bressan, GC; Brik, A; Brizuela, A; Brockbank, KGM; Buchner, F; Bunc, M; Buscombe, JR; Butler, AJ; Buzaleh, AM; Buzin, MI; Cabrera-Capetillo, CA; Calvo, AM; Camerota, A; Campagna, G; Campisi, M; Cano, K; Cao, HST; Cardellini, S; Carvalho, AP; Carvalho, BCR; Castillo-Baltazar, OS; Cataldo, P; Chai, P; Chakraborty, S; Chalo, DM; Chan, MY; Chander, S; Changbunjong, T; Chappuis, CJF; Chee, RCH; Chen, C; Chen, CJ; Chen, E; Chen, M; Chen, X; Chen, Y; Cheng, HT; Cheng, MC; Cheow, HK; Chi, Y; Chirikova, NK; Chiu, SH; Cho, G; Cho, HR; Cho, S; Cho, SJ; Choe, A; Choe, YH; Chun, BS; Chun, Z; Cinque, A; Ciopec, M; Cladas, Y; Cleary, SP; Clermont, O; Cléroux, M; Cockburn, J; Collares, FM; Colombini-Ishikiriama, BL; Conn, BN; Cortina, JL; Cox, DRA; Crini, G; Croker, R; Cursaru, DL; Curtis, HJ; da Silva, KJG; Dalla Costa, T; Davy, S; de Araújo, BV; de Cassia Ribeiro Gonçalves, R; de Gaetano, F; de Gregorio, C; de Oliveira, MG; De Vera, MAT; de Vos, M; de-la-Fuente, I; Dell'Oca, I; Delles, M; Déméautis, T; Dempster, M; Deng, YH; Denisenko, Y; Descombes, C; Desideri, G; Devarbhavi, H; Devouassoux, G; Di Bella, G; Di Marco, F; Diao, Y; Dias, BB; Dilgin, Y; Dimopoulou, I; Dionísio, TJ; Dobrovic, A; Dokin, ES; Dolby, T; Dong, X; Dong, Y; Dou, SX; Douglas, IJ; Dousset, S; Du, Z; Duan, M; Duan, SB; Duke-Williams, O; Duteanu, N; Dutertre, S; Dutta, S; Dwyer, MG; Ebenbauer, J; Eggo, RM; El-Mordy, FMA; Elbhnsawi, NA; Elrehany, MA; Elshewemi, SS; Elwakil, BH; Emadzadeh, D; Eraso, E; Ermolenko, E; Erten, K; Ettorre, E; Evans, D; Evans, SJ; Faheem, M; Fallanza, M; Faramarzi, M; Faria, FAC; Faro, DC; Fatma, YS; Fazil, S; Feng, Y; Ferguson, J; Fernandes, MH; Fernández-Domínguez, M; Ferrari, LAL; Ferraz, EP; Ferreira, LC; Ferri, C; Fikry, M; Floris, M; Forbes, H; Fotouh, B; Franke, K; Freitas, AC; Freitas, GP; Frieboes, HB; Fu, B; Fu, Y; Fukina, DG; Fukuda, DH; Fukunaga, K; Fulham, GJ; Furlan, L; Furtado Mesa, M; Furtunescu, FL; Gabbieri, D; Ganash, M; Gebers, JC; Gehman, V; Ghaedi, A; Ghazali, NSM; Ghebrekristos, Y; Gil, J; Gilbert, NM; Gimenes, R; Giordano, L; Glehen, O; Godeau, C; Goh, SK; Goldacre, B; Gomes, AM; Gomes, MPO; Gomes, PS; Gomes, RMODS; Gómez-Coma, L; Grenho, L; Gu, Q; Gu, T; Gu, YC; Guiducci, V; Guillemin, JP; Guo, W; Guo, YW; Gur, E; Guridi, A; Guzmán-López, A; Gvozdenko, T; H Elmaidomy, A; Hagar, M; Haider, S; Han, JM; Hanratty, J; Hans, R; Haque, N; Harharah, HN; Harharah, RH; Harper, S; Hasegawa, N; Hassanin, AH; Hastuti, YP; Hatem, AE; He, R; He, Y; Heinemann, C; Heinmaa, I; Heinzl, F; Helfer, VE; Hester, F; Hickman, G; Hill, MA; Hill, WG; Hintze, V; Ho, JSY; Ho, LY; Hoang, T; Holzer, I; Houbraken, J; Hsu, CN; Hu, J; Hu, X; Hu, Y; Hua, T; Huang, Z; Hulme, WJ; Hunter, A; Ianăşi, C; Ibañez, R; Iezzi, R; Iliuță, L; Im, YM; Imran, M; Inglesby, P; Inguimbert, N; Iqbal, A; Izawa, N; Jahaj, E; Jain, S; Jakimovski, D; Jalal, MM; Jaroszuk-Ściseł, J; Jasim, DJ; Jauregizar, N; Javle, MM; Jędryczka, M; Ji, H; Jiang, Y; Jin, J; Johnson, NT; Joshi, S; Jullok, N; Kachapulula, PW; Kaczmarek, J; Kaczmarek-Szczepańska, B; Kadota, K; Kaji, M; Kakeji, Y; Kakizoe, S; Kakudidi, E; Kalitukha, L; Kamata, H; Kang, YJ; Kapinos, AA; Karakaya, S; Kashchenko, NI; Kasyanov, S; Kataky, R; Katati, B; Kato, G; Katsina, AU; Kaya, A; Kaya, H; Kazarina, OV; Ke, Y; Keenan, C; Keilson, JM; Keshavan, A; Keskinidou, C; Khalifa, MA; Khan, R; Khan, S; Kim, D; Kim, K; Kim, MS; Kim, SM; Kim, WH; Kim, Y; Kim, YJ; Kishimura, H; Kitagawa, RR; Klemenkova, ZS; Kloss, F; Kobayashi, N; Kohlhoff, M; Kong, WKF; Konsek, H; Kornaros, M; Kotanidou, A; Kovacs, S; Kraska, J; Kruppke, B; Kumagai, Y; Kumar, S; Kumari, R; Kuruva, V; Kuster, RM; Kusumoto, T; Kutyła, M; Kwon, JH; Kwon, SH; Kwong, KY; Kyser, AJ; Lackner, M; Lass-Flörl, C; Lauri, C; Lavandera, JV; Lee, BH; Lee, ECY; Lee, HJ; Lee, J; Lee, PS; Lee, S; Lee, SE; Lee, SY; Lefort, F; Leite, JPV; Leo, G; Leonard, R; Leow, AST; Lepori, N; Leyden, K; Leys, L; Ležaić, L; Li, D; Li, H; Li, J; Li, S; Li, TYW; Li, X; Li, XH; Li, Y; Li, Z; Li, ZH; Liao, S; Liaqat, K; Lim, H; Lin, BS; Lin, MY; Lin, NH; Lin, X; Lin, Y; Liu, C; Liu, H; Liu, HK; Liu, HX; Liu, P; Liu, R; Liu, T; Liu, X; Liu, Y; Lock, GA; Lokaj, G; Lopes, HB; Losi, V; Lotsios, NS; Low, KE; Lu, Z; Luhana, S; Luo, X; Luo, XQ; Lutz, MB; Lysova, AA; Lyssenko, KA; Macit, M; MacIver, B; MacKenna, B; Magalhães, GAP; Magnavacchi, P; Mahadevan, J; Mahboubi, A; Maher, SA; Mahipal, A; Mahmoud, MY; Maithel, SK; Makhtar, MMZ; Makurat-Kasprolewicz, B; Malysheva, YB; Mansourizadeh, A; Marek, EJ; Maresca-Fichter, H; Martin, JT; Maslov, AA; Mastora, Z; Mastroiacovo, D; Mastropetros, SG; Matei, D; Mathur, R; Matos, AO; Matsuda, Y; Maurya, SK; Mayor, Á; Mayrhofer, D; Mazzuco, AC; McCaffrey, J; McClure, T; McDonald, HI; Mchunu, NP; McLaggan, D; Mehrkar, A; Meilik, B; Melito, VA; Mellem, J; Mengozzi, A; Menotti, J; Mesquita, V; Miao, Z; Mihai, S; Miller, S; Minassian, C; Mirabile, A; Mitra, S; Mladin, G; Mo, Z; Moawad, H; Mohamed, EM; Mohammed, TJ; Mohanlall, V; Mohyeldin, RH; Moldovan, H; Monneret, G; Monopoli, DE; Monte, IP; Monteiro, JRB; Morgante, V; Mori, M; Morin-Crini, N; Morita, A; Morton, CE; Mrak, M; Muhammed, AP; Mulick, A; Muralidharan, V; Murthy, P; Muselli, M; Mustafa, S; Mysore Visweswariah, A; Nagao, G; Naicker, S; Nakagawara, K; Namgoong, B; Namkoong, H; Namukobe, J; Nasir, AA; Nasreen, SA; Natarajan, P; Nchiozem-Ngnitedem, VA; Necozione, S; Negrea, A; Negrea, P; Ngubane, S; Nguyen, TT; Nicke, A; Nightingale, E; Nistor, CL; Nitsch, D; Njapau, H; Noman, M; Novgorodtseva, T; Nowak, A; O'Connor, SR; Ofoe, R; Oh, K; Oh, TH; Oki, E; Olama, ZA; Olennikov, DN; Oliveira, GM; Omar, D; Ong, SJ; Orfanos, SE; Origa-Oryem, H; Orita, H; Ortiz, I; Ota, M; Ott, J; Otvagina, KV; Pacheco, N; Pacheco, RR; Padmanabhan, D; Pagan, JD; Pagnotta, PA; Palangi, V; Palanisamy, G; Palanisamy, K; Palanisamy, S; Pan, SG; Panaitescu, E; Pang, X; Panoutsakopoulos, V; Parera, VE; Park, JI; Park, JS; Park, SW; Park, Y; Park, YS; Parkash, O; Parry, J; Parry, JP; Paul, SK; Pavšič, N; Pałubicka, A; Persat, F; Petriz-Prieto, MA; Petukhov, AN; Pham, T; Pillay, S; Poh, KK; Ponomarev, II; Pontons-Melo, JC; Posa, A; Powell, E; Priya, AK; Punekar, R; Puppin Rontani, RM; Purushottam, M; Pusphanathan, K; Qi, JY; Qin, J; Qin, Z; Qiu, B; Qiu, X; Quattrini, G; Quindós, G; Qureshi, F; Rabbany, MA; Rac-Albu, M; Rac-Albu, ME; Rădulescu, BC; Rafatullah, M; Rajab, TK; Rajna, S; Ramanathan, M; Rao, D; Raviglione, D; Razorenov, DY; Redd, MJ; Rehman, W; Reig, M; Rentsch, CT; Ribeiro, LMS; Robles, D; Rocchi, S; Rocha, FG; Rodrigues, C; Rodrigues, LA; Rodrigues, RP; Roh, GH; Ronowska, A; Root, A; Rosa, AL; Rossi, R; Roy, S; Roy, VC; Rupji, M; Saber, EA; Sadarat, F; Saed, Y; Saeed, WS; Saeki, H; Saha, B; Saiwichai, T; Sakowicz-Burkiewicz, M; Sampedro, T; Sands, K; Santos, CF; Sari, M; Sathi, FA; Sauro, S; Sazanova, TS; Scafa-Udriște, A; Schoustra, SE; Schultze, A; Seo, DJ; Sevillano, E; Sezmis, G; Sgura, FA; Shah, NNAK; Shani, N; Shankarappa, B; Sharkey, LM; Sharma, VK; Sharp, C; Shehata, N; Shelton, N; Shieh, PB; Shimokawa, M; Shin, J; Shin, SH; Shin, YN; Shin, YR; Shipilova, A; Shoparwe, NF; Shukor, H; Sia, CH; Siddiqui, MH; Siddiqui, MR; Siena, V; Signore, A; Silwane, B; Siqueira-Sandrin, VS; Siregar, A; Sirignano, P; Sit, NW; Skidmore, S; Skupov, KM; Smeeth, L; Smoczer, C; Smolyanskiy, E; Sohn, H; Solodeev, I; Solovyev, A; Şomoghi, R; Song, F; Song, H; Song, Z; Souf, YM; Sousa, SC; Souza, MT; Steinbach-Rankins, JM; Stockton, J; Stout, JR; Su, K; Su, MZ; Suarez-Lopez, YA; Sukkurd, R; Sultanov, R; Sun, Y; Sun, Z; Supernak, M; Supriyono, E; Suroshe, SS; Suvorov, SS; Svera M Ianăşi, P; Switchenko, JM; Syarif, NY; Synytsya, A; Taherzadeh, MJ; Tain, YL; Tamburino, C; Tammam, OY; Tan, BYQ; Tan, H; Tan, S; Tanaka, H; Tang, R; Tang, X; Tang, Z; Taurino, M; Tazare, J; Teresi, L; Testro, A; Thanasoponkul, W; Thangarasu, S; Thavaselvam, D; Theodoro, RC; Theron, G; Thomas, RH; Thomson, JJ; Tian, X; Tian, Y; Tomaszewski, CA; Tomlinson, LA; Torres, CMME; Tóth, M; Trecourt, A; Trevisani, F; Trimarchi, G; Tristán, C; Truong, VK; Tsigkou, K; Tsutsumi, S; Ubukata, Y; Uehara, H; Uwamino, Y; Vahedi-Shahandashti, R; Valberg, SJ; Valderrama, C; Valdovinos-García, EM; Valsecchi, D; van Diepeningen, AD; van West, P; Vargas-Osuna, E; Vassall, M; Vassilaki, N; Vassiliou, AG; Vecino, X; Velez-Irizarry, D; Venkatesh, YN; Vignali, L; Virdis, A; Viswanath, B; Voisin, AS; Volkova, YA; Vorotyntsev, AV; Vorotyntsev, IV; Vtyurina, ES; Vu, DH; Waldridge, B; Walker, AJ; Wallon, M; Wang, B; Wang, G; Wang, H; Wang, J; Wang, LJ; Wang, S; Wang, T; Wang, X; Wang, Z; Warren, RM; Warren-Gash, C; Wei, SH; Weinstock-Guttman, B; Wekwejt, M; Wessjohann, LA; Wiesmann, HP; Williams, ZJ; Williamson, EJ; Wilson, M; Wing, K; Wong, AY; Wong, BKL; Woodward, S; Wozniak, KL; Wu, C; Wu, K; Wu, S; Wu, Y; Xiang, D; Xie, H; Xiong, X; Xu, C; Xu, H; Xu, J; Xu, WH; Xu, Y; Xun, T; Yamaguchi, S; Yan, P; Yan, W; Yan, Z; Yang, B; Yang, F; Yang, L; Yao, XB; Yasui, H; Yenesew, A; Yeo, LLL; Yeo, TC; Yi, S; Yin, F; Yip, JWL; Yoon, SH; Yoon, SJ; Yoshida, M; Yoshizumi, T; Young, LA; Yu, C; Yu, DD; Yu, F; Yu, H; Yu, JD; Yu, NJ; Yu, X; Yuan, Y; Yurenko, A; Yusof, YA; Zahedipoor, A; Zahran, EM; Zainuddin, NI; Zanatta, AC; Zanotto, ED; Zanozin, ID; Zavascki, AP; Zenke, M; Zhang, F; Zhang, G; Zhang, H; Zhang, J; Zhang, L; Zhang, MX; Zhang, NY; Zhang, Q; Zhang, W; Zhang, X; Zhang, XM; Zhao, F; Zhao, Q; Zhao, R; Zhao, Y; Zheng, J; Zheng, S; Zhou, L; Zhou, X; Zhu, H; Zivadinov, R; Žižek, D; Zuccoli, JR; Zwaan, BJ | 1 |
Bakthavatchalam, YD; Bano, N; Dubey, D; Dubey, M; Imran, A; Jain, B; Kulshrestha, V; Mitra, S; Roy, M; Sangwan, P; Shah, TH; Veeraraghavan, B; Velmurugan, A | 1 |
Elshaboury, RH; Huang, J; Letourneau, AR; Monk, M; Winkler, ML | 1 |
Aiken, AM; Cocker, D; de Kraker, MEA; Dramowski, A; Fwoloshi, S; Hemed, A; Iregbu, KC; Kagucia, E; Kawaza, K; Kebede, M; Labi, AK; Lester, R; Madrid, L; Medugu, N; Nwajiobi-Princewill, PI; Nyamwaya, B; Obeng-Nkrumah, N; Ojok, D; Rehman, AM; Scott, JAG; Sonda, T; Whitelaw, A | 1 |
Al-Marzooq, F; Allam, M; Collyns, T; Daoud, L; Ghazawi, A; Saleem, A | 1 |
Flamm, RK; Pfaller, MA; Shortridge, D; Streit, JM | 1 |
Dramowski, A; Feasey, NA; Garner, P; Hamer, DH; Lester, R; Musicha, P; van Ginneken, N | 1 |
DeBurger, B; Khalil, N; Mortensen, JE; Powell, EA | 1 |
Bührer, C; Dame, C; Garten, L; Longardt, AC; Piening, B; von Weizsäcker, K | 1 |
Bonten, MJM; Deelen, JWT; Giron Ortega, JA; Harbarth, S; Jacobsson, G; Rodriguez-Baño, J; Rottier, WC; Tacconelli, E; van Werkhoven, CH; Zahar, JR | 1 |
Carvalhaes, CG; Castanheira, M; Mendes, RE; Sader, HS; Streit, JM | 1 |
Ariyasu, M; Bassetti, M; Doi, Y; Echols, R; Ferrer, R; Lodise, TP; Matsunaga, Y; Naas, T; Nagata, TD; Niki, Y; Paterson, DL; Portsmouth, S; Torre-Cisneros, J; Toyoizumi, K; Wunderink, RG | 1 |
Bassetti, M; Giacobbe, DR; Pelosi, P; Robba, C; Vena, A | 1 |
Echols, R; Katsube, T; Kawaguchi, N; Wajima, T | 1 |
Ben-Ami, R; Bitterman, R; Cheng, MP; Chowers, M; Geffen, Y; Huberman Samuel, M; Koppel, F; Lee, TC; Leibovici, L; Mussini, C; Nesher, L; Paul, M; Rahav, G; Turjeman, A; Yahav, D | 1 |
de Vries Schultink, AHM; Meinders, AJ; Roescher, N; Sallevelt, BTGM; van de Garde, EMW | 1 |
Chatfield, MD; Harris, PNA; Littleford, R; Paterson, DL; Stewart, AG | 1 |
Corey, A; So, TY | 1 |
Cho, YL; Kim, HS; Kwak, JH; Oh, K; Oh, SH; Park, HS; Yun, JY | 1 |
Mueller, BA; Shaw, AR | 1 |
Goodlet, KJ; Nailor, MD; Nicolau, DP | 1 |
Gavin, HE; Satchell, KJF; Trinh, SA | 1 |
Caughey, AB; Niu, B; Skeith, AE; Tuuli, MG; Valent, AM | 1 |
Forstner, C; Pletz, MW; Wagenlehner, F; Weis, S | 2 |
Dhanda, RS; Gaind, R; Mittal, G; Nagarjuna, D; Yadav, M | 1 |
Bernards, ST; de Boer, MGJ; Hendriks, BJC; Lambregts, MMC; Visser, LG | 1 |
Alemkere, G; Engidawork, E; Tenna, A | 1 |
Bernard, S; Lee, K; Pakyz, A; Stevens, M; Vaughan, D | 1 |
Bodmann, KF | 1 |
Darboe, KS; Jang, HC; Jung, SI; Kang, SJ; Kim, SE; Kim, UJ; Oh, TH; Park, KH; Shin, HY; Shin, SU | 1 |
Bassah, N; Ebob-Anya, BA; Palle, JN | 1 |
Falagas, ME; Karageorgopoulos, DE; Korbila, IP; Tansarli, GS; Vardakas, KZ | 1 |
Hino, R; Kabashima-Kubo, R; Nakamura, M; Sawada, Y | 1 |
Bosch, J; Guiral, E; López, Y; Montero, I; Sáez-López, E; Soto, SM; Vila, J | 1 |
Doi, Y; Qureshi, ZA | 1 |
Ammerlaan, HS; Bamberg, YR; Bonten, MJ; Dorigo-Zetsma, JW; Rottier, WC; van der Linden, PD | 1 |
Farrell, DJ; Flamm, RK; Jones, RN; Sader, HS | 1 |
Asari, Y; Itoga, M; Kayaba, H; Morimoto, T; Nakamura, K; Okumura, K; Taima, K; Takanashi, S; Tanaka, H; Tanaka, Y | 1 |
Geerlings, SE; Holleman, F; Schneeberger, C | 1 |
Fujiwara, S; Hadano, Y; Inoue, T; Kataoka, Y; Matsumoto, K; Morino, K; Shimizu, T; Takada, S | 1 |
Gourley, G; Satrom, K | 1 |
Abdulsalam, A; Kamaldeen, B; Roaa, Z; Shahid, G; Tariq, AF | 1 |
Domínguez-Herrera, J; Labrador-Herrera, G; López-Rojas, R; Pachón, J; Smani, Y | 1 |
Daribay, Z; Dossimbetova, M; Rakhmetullina, G; Saduov, M; Tussupkaliyev, A | 1 |
Agarwal, SK; Bhowmik, DM; Gupta, A; Lal, C; Mahajan, S | 1 |
Heckeroth, A; Leendertse, I; Rohdich, N; Thomas, E; Wilhelm, C; Zschiesche, E | 1 |
Rothfuss, P | 1 |
Doherty, JA; Khan, J; Kollef, MH; Micek, ST; Pervez, M; Reichley, RM; Welch, EC | 1 |
Chan, KS; Chuang, YC; Kuo, CY; Tsai, CL; Yu, WL | 1 |
Eb, F; Guillon, H; Mammeri, H | 1 |
De Backer, D; Delattre, I; Dugernier, T; Jacobs, F; Laterre, PF; Layeux, B; Spapen, H; Taccone, FS; Vincent, JL; Wallemacq, P; Wittebole, X | 1 |
Aguilar, L; Alou, L; Cafini, F; Coronel, P; García, E; Giménez, MJ; González, N; Prieto, J; Ramos-Sevillano, E; Sevillano, D; Torrico, M; Yuste, J | 1 |
Boĭko, VV; Ivanova, IuV | 1 |
Beloborodov, VB; Gruver, KP; Kuz'menko, TN | 1 |
Aziz, NA; Chong, CP; Lim, PP | 1 |
Fünfstück, R; Naber, KG; Olschläger, T; Wagenlehner, FM | 1 |
Bozzini, G; Carmignani, L; Marenghi, C; Mombelli, G; Pace, G | 1 |
Delattre, IK; Jacobs, F; Jacqmin, P; Laterre, PF; Musuamba, FT; Taccone, FS; Verbeeck, RK; Wallemacq, P | 1 |
Cullen, IM; Fennell, JP; Flynn, RJ; Grainger, R; Manecksha, RP; McDermott, T; McEvoy, E; Nason, GJ; Thornhill, JA | 1 |
Coutinho, AS; de Morais, OO; de Oliveira Carneiro da Motta, J; Gomes, CM | 1 |
Schumacher, J; Seibert, R; Steeil, J; Tobias, K | 1 |
Beumier, M; Cotton, F; De Backer, D; Hites, M; Jacobs, F; Lorent, S; Roisin, S; Seyler, L; Surin, R; Taccone, FS; Vincent, JL; Wolff, F | 1 |
Delle-Karth, G; Heinz, G; Joukhadar, C; Klein, N; Kreischitz, N; Mayer, BX; Müller, M; Palkovits, P | 1 |
Azeh, I; Eiffert, H; Gerber, J; Koenig, B; Nau, R; Wellhausen, M; Wellmer, A | 1 |
Deenichin, G; Delikostadinov, G; Dimov, R; Doikov, I; Stefanov, C | 1 |
Badaró, R; Massud, J; Mendonça, J; Molinar, F; Nascimento, LO; Seas, C; Stamboulian, D | 1 |
Aeberhard, P; Billing, A; Böcker, I; Gebhard, B; Ohmann, C; Röhrborn, A; Schäfer, V; Schöffel, U; Wacha, H | 1 |
Bilikova, E; Chovancova, D; Hafed, BM; Huttova, M; Koprnova, J; Kovacicova, G; Krcmery, V; Svetlansky, I | 1 |
Nakahama, C | 1 |
Oishi, K | 1 |
Banks, SM; Cui, X; Eichacker, PQ; Gerstenberger, E; Hartung, T; Karzai, W; Mehlhorn, B; Natanson, C; Reinhart, K; Straube, E | 1 |
Carlson, P; Hiilesmaa, V; Kankuri, E; Kurki, T | 1 |
Azi, M; Boussemart, T; Manouana, M; Perez, JM; Piet-Duroux, S; Port-Lis, M | 1 |
Miyazaki, S; Okazaki, K; Tsuji, M; Yamaguchi, K | 1 |
Anstey, NM; Cheng, AC; Currie, BJ; Fisher, DA; Jacups, SP; Stephens, DP | 1 |
Eggers, V; Fügener, K; Hein, OV; Heyes, MP; Kox, WJ; Rommelspacher, H; Spies, CD | 1 |
Ohyashiki, K | 1 |
Bassaris, HP; Drosou, E; Gogos, CA; Lekkou, A; Marangos, MN; Skoutelis, A; Starakis, I | 1 |
Adamis, T; Baziaka, F; Giamarellos-Bourboulis, EJ; Giamarellou, H; Karayannacos, PE; Koussoulas, V; Mouktaroudi, M; Perrea, D | 1 |
Delle-Karth, G; Georgopoulos, A; Joukhadar, C; Marsik, C; Mayer-Helm, BX; Müller, M; Sauermann, R; Steiner, I; Zeitlinger, M | 1 |
Bilgic, H; Coskun, O; Edremitlioglu, M; Kilic, D; Kisa, U; Korkmaz, A; Oter, S; Yaren, H | 1 |
Jeljaszewicz, J; Mészáros, J; Stachlewska, E; Tołłoczko, T; Tyc, Z | 1 |
Naylor, JM | 1 |
Gabisoniia, NZ; Kharashvili, VI; Khochava, MA | 1 |
Dan, K; Yokose, N | 1 |
Agarwal, N; Agarwal, S; Arya, SC; Solanki, BS | 1 |
Guchev, IA | 1 |
Asseff, IL; Guillé, GP; Olguín, HJ; Pérez, AG; Quesada, AC; Saldaña, NG; Vieyra, AC | 1 |
McKinnon, PS; Paladino, JA; Schentag, JJ | 1 |
Ricciardiello, PT; Stangalini, A; Toscano, F | 1 |
Austrian, R; Tempest, B | 1 |
Celozzi, E; Gadebusch, HH; Pelak, BA; Stapley, EO | 1 |
Klesel, N; Limbert, M; Schrinner, E; Seibert, G; Winkler, I | 1 |
Brown, RM; Eykyn, SJ; Farrell, ID; Geddes, AM; Gozzard, DI; Phillips, I; Wise, R | 1 |
Shah, PM; Stille, W | 1 |
Beaucaire, G; Caillaux, M; Deboscker, Y; Fourrier, A; Mouton, Y | 1 |
Carruthers, M; Cook, FV; Emmerman, J; Phair, JP; Reisberg, BE; Venezio, FR; Westenfelder, GO; Williams, JE | 1 |
Dusehu, E; Lallement, PY; Philippe, JM; Veyssier, P | 1 |
McCall, CE; Pegram, PS; Salzer, W | 1 |
Shinohara, T | 1 |
Armengaud, M; Aubertin, J; Bertrand, A; Carbon, C; Dureux, JB; Gouin, F; Goulon, M; Leng, B; Motin, J; Mouton, Y; Portier, H; Salord, JC; Veyssier, P | 1 |
Alestig, K; Brorson, JE; Eilard, T; Norrby, R; Svensson, R; Trollfors, B | 1 |
Ishibiki, K | 1 |
Clément, M; Francioli, P; Geroulanos, S; Luthy, R; Regamey, C; Stalder, H; Vogt, M; von Graevenitz, A; Waldvogel, FA | 1 |
Gimbrère, JS; Muytjens, HL; van Dalen, R | 1 |
Jarstrand, C; Lundbergh, P; Morfeldt-Månson, L; Weiland, O | 1 |
Callies, R; Siekmann, U | 1 |
Armengaud, M; Aubertin, J; Bertrand, A; Lepeu, G; Massip, P; Ragnaud, JM | 1 |
Helm, EB; Shah, PM; Stille, W | 2 |
Bax, R; Geddes, AM; McKendrick, MW; Wise, R | 1 |
Blomer, RJ; Bruch, K; Husson, JM; Savopoulos, C; Young, JP | 1 |
Fabricius, K; Riegel, H | 1 |
Armengaud, M; Aubertin, J; Bertrand, A; Lepeu, G | 1 |
Bastin, R; Bure, A; Frottier, J; Vilde, JL | 1 |
Canton, P; Dureux, JB; Gérard, A; Roche, G; Weber, M | 1 |
Boussougant, Y; Carbon, C; Destaing, F; Portier, H | 1 |
Gajdos, P; Goulon, M; Pilliot, J | 1 |
Aguirre, M; Alés, JM; Torres, A | 1 |
Andrews, JA; Geddes, AM; McKendrick, MW; Wise, R | 1 |
Hyams, KC; Mader, JT; Parks, DH; Pollard, RB; Reinarz, JA; Thomson, PD | 1 |
Cohen, E; Mogabgab, WJ | 1 |
Bégué, P; Brun, Y; Fleurette, J; Floret, D; Monnet, P; Safran, C | 1 |
Carbon, C | 1 |
Acar, JF | 1 |
Schaad, UB | 2 |
Mitchell-Jones, PJ; Sankey, RJ | 1 |
Fujii, R; Kim, B; Mashiko, J; Meguro, H; Nakajo, M; Ohnari, S; Tajima, T | 1 |
Abbas, AM; Cantor, AM; Haste, AR; Jones, RB; Newby, D; Rigby, CC; Taylor, MC | 1 |
Hellum, KB; Ingram, PM; Svarva, PL; Walstad, RA | 1 |
Delogu, G; Gasparetto, A | 1 |
Gravert, C; Sack, K; Schulz, E | 1 |
Bouza, E; Hellín, T; Loza, E; Martínez-Beltrán, J; Rodríguez-Creixems, M; Sanz-Hospital, J | 1 |
Delisle, R; Pechère, JC | 1 |
Butzler, JP; Clumeck, N; Dab, I; Gordts, B; Jaspar, N; Van Laethem, Y | 1 |
Fliegelman, RM; Karakusis, PH; Levin, S; Pottage, JC; Trenholme, GM | 1 |
Harnoss, CM; Kemmerich, B; Koeppe, P; Lode, H; Wagner, J; Warns, H | 1 |
Norrby, SR | 1 |
El-Sadr, W; Maslow, MJ; Pollock, AA; Press, RA; Rahal, JJ; Richmond, AS; Rosenberg, A; Silverman, D; Simberkoff, MS | 1 |
Neu, HC; Scully, BE | 1 |
Iseki, M; Iwasaki, Y; Iwata, S; Jozaki, K; Kasai, Y; Ogata, T; Osano, M; Sato, Y; Sunakawa, K; Yamashita, R | 1 |
Watanakunakorn, C | 1 |
Kunii, O; Mashimo, K | 1 |
Mirrett, S; Reimer, LG; Reller, LB | 1 |
Abger, G; Handrick, W; Helbig, W; Jung, N; Kirsch, WD; Kleint, V; Menzel, B; Siegenthaler, W; Spencker, FB; Tauchnitz, C | 1 |
Avent, CK; Cobbs, CG; Dismukes, WE; Elliott, AM; Livingston, WK | 1 |
Carson, M; McDonald, M; Miles, H | 1 |
Kim, JP; Kim, SJ | 1 |
Busuttil, RW; Kurtz, TO; Winston, DJ; Young, LS | 1 |
Böttcher, W; Germann, G; Seufert, RM | 1 |
Coppens, L; Hanson, B; Klastersky, J | 1 |
Forsgren, A; Ode, B; Walder, M | 1 |
Schreiner, A | 1 |
Lode, H | 1 |
Neu, HC | 1 |
Balmayer, B; Bertrand, A; Despaux, E; Janbon, F; Jonquet, O; Lepeu, G; Santoni, A | 1 |
Chau, PY; Leung, YK; Ling, J; Ng, WS | 1 |
DiCostanzo, MB; Grieble, HG; Krause, SL; Pappas, SA | 1 |
Coppens, L | 1 |
Goering, RV; Sanders, CC; Sanders, WE | 1 |
Bailey, RR; Reddy, J | 1 |
McAllister, TA | 1 |
Baba, Y; Fujimoto, T; Ishimoto, K; Komatsu, R; Kusayanagi, T; Motohiro, T; Nishiyama, T; Onoda, Y; Sakata, Y; Tanaka, C; Tominaga, K; Toubo, Y; Tsuboi, M; Yamamoto, M; Yamashita, F | 1 |
Gutiérrez-Núñez, J; Harrington, PT; Ramirez-Ronda, CH | 1 |
Gadebusch, HH; McRipley, RJ; Whitney, RR | 1 |
Feldman, WE; Keyserling, H; Olsson, JM | 1 |
Hawe, RS | 1 |
Crenshaw, CA; Glanges, E; McReynolds, DB; Webber, CE | 1 |
Chiesa, C; Midulla, F | 1 |
Carney, DN; Fossieck, BE; Parker, RH | 1 |
Goetz, MB; Jones, J | 1 |
De Carvalho, EM; De Oliveira, MM; Martinelli, R; Rocha, H | 1 |
Bar-Moshe, O; Chamali, R; Ghosen, V; Stenier, P | 1 |
Righter, J | 1 |
Ansanelli, V; Di Lena, C; Jafusco, F | 1 |
Auckenthaler, R; Waldvogel, FA | 1 |
Hess, OM; Lüthy, R; Siegenthaler, W; Youssef, S | 1 |
Montgomerie, JZ; Ota, JK | 1 |
Dornbusch, K; Hugo, H; Sterner, G | 1 |
Abbasi, S; Chesney, PJ; Davis, Y; Day, SW; Leggiadro, RJ; Presbury, G; Schutze, GE; Wang, WC; Wilimas, JA | 1 |
Guthertz, LS; Janda, JM; Kokka, RP; Shimada, T | 1 |
Branger, JM; Hoepelman, AI; Kieft, H; Knupp, CA; Struyvenberg, A; van Dijk, A; Verhoef, J | 1 |
Bertrand, A; Chidiac, C; Dellamonica, P; Humbert, G; Leroy, J; Micoud, M; Modai, J; Mouton, Y; Stahl, JP; Veyssier, P | 1 |
Powell, BJ; Scarbrough, F; Shrout, MK | 1 |
Aspinall, S; Connell, C; Corkill, J | 1 |
Broerse, HM; de Groot, R; Neijens, HJ; Schoemaker, RC; van den Anker, JN; van der Heijden, BJ | 1 |
Bizette, GA; Bradford, HB; Cole, JT; Kemmerly, SA; Peltier, BH | 1 |
Dopff, C; Gérard, A; Le Meins, V; Maurer, P; Witz, B | 1 |
Deguchi, K; Fukayama, S; Fukumoto, T; Ishihara, R; Koguchi, M; Nakane, Y; Oda, S; Suzuki, Y; Tanaka, S | 1 |
Banas, B; Combe, C; Manns, MP; Schlöndorff, D; Zoller, WG | 1 |
Albrecht, H; Bubert, A; Elsner, HA; Laufs, R; Mack, D; Sobottka, I | 1 |
Burroughs, AK; Chin, JK; Greenslade, L; Kibbler, CC; McCormick, PA; McIntyre, N | 1 |
Eppes, S; Salen, PN | 1 |
Carton, D; Gamiz-Jimenez, J; Renders, F; Robberecht, E; Van Winckel, M; Vlaminck, H | 1 |
Bergfeld, WF; Rindler, JM; Ruddock, TL | 1 |
Hungerford, DS; Mont, MA; Waldman, BJ | 1 |
Van Deynse, E; Van Noyen, G; Van Noyen, R; Vermijlen, P | 1 |
Carroll, JM; Stallworth, JR | 1 |
Degener, JE; Kosterink, JG; Mulder, JG | 1 |
Klastersky, J | 1 |
Alveyn, CG; Davis, AJ; Kolios, G; Robertson, DA | 1 |
Marchisio, P; Principi, N | 1 |
Geddes, AM; Norrby, SR; Shah, PM | 2 |
Fujiyama, S; Tanaka, M | 1 |
Bijlsma, JW; Blaauw, AA; Bongers, V; Hoepelman, AI | 1 |
Hart, S | 1 |
Horiike, S; Iwai, T; Kaneko, H; Kashima, K; Misawa, S; Nakazawa, N; Ohgawara, Y; Sasai, Y; Tamura, A; Taniwaki, M; Tsuda, S; Ueda, Y; Yokota, S | 1 |
Kofler, J; Stanek, C | 1 |
Fleer, A; Gerards, LJ; Jones, ME; Krediet, TG | 1 |
Asumang, A; Dryden, M; Goldsmith, AL | 1 |
Dan, K; Furuya, T; Harada, Y; Hirosawa, S; Ikeda, Y; Kawaguchi, M; Kawamata, N; Kawano, K; Kikuchi, M; Matsuoka, S; Murakami, H; Onozawa, Y; Oshimi, K; Sawanobori, M; Shirota, T; Suzuki, K; Takeuchi, J; Tomoyasu, S; Toyama, K; Tsuruoka, N; Uchida, Y; Wakasugi, K; Yaguchi, M; Yamada, T; Yamamoto, K | 1 |
Hagn, J; Heinritzi, K | 1 |
Bergman, R; Friedman-Birnbaum, R; Sprecher, E | 1 |
Galloway, A; Glesson, HK | 1 |
Hussey, G; Zar, HJ | 1 |
Baden, L; Thomas, LR; Zaleznik, DF | 1 |
Claeys, G; De Baere, T; Peleman, R; Steyaert, S; Vaneechoutte, M; Verschraegen, G | 1 |
Dormann, AJ; Grünewald, T; Huchzermeyer, H; Kleimann, F; Kloppenborg, A; Risius, H; Wigginghaus, B | 1 |
Buys, E; DeLuca, J; Stringel, G; Wichtel, ME | 1 |
Mykhaĭlovych, IuI | 1 |
Lim, JK; Yap, KB | 1 |
Alekseeva, EA; Belotserkovskiĭ, BZ; Gel'fand, BR; Gel'fand, EB; Karabak, VI; Tsedenzhapov, ETs | 1 |
Isaacs, D | 1 |
Fijen, JW; Ligtenberg, JJ; Möller, AV; Spanjersberg, R; Stegeman, CA; Tulleken, JE; Van de Merbel, NC; Van der Werf, TS; Zijlstra, JG | 1 |
Horn, DL; Morrison, DC; Norimatsu, M; Silverstein, R; Wood, JG; Xue, Q | 1 |
de Man, P; van den Anker, JN; Verbrugh, HA; Verhoeven, BA; Vos, MC | 1 |
Aoki, K; Asano, S; Bessho, M; Fujita, A; Furusawa, S; Higashihara, M; Hirai, H; Hoshino, S; Hotta, T; Kitamura, K; Koike, M; Kuraishi, Y; Kurihara, I; Mizoguchi, H; Nagoshi, H; Nishimura, M; Nonaka, Y; Ohbayashi, Y; Omine, M; Oshimi, K; Ozawa, K; Suzuki, K; Takaku, F; Togawa, A; Urabe, A; Wakabayashi, Y | 1 |
Caksen, H; Oztürk, MK; Ustünbaş, HB; Uzüm, K; Yüksel, S | 1 |
Armstrong, MA; Bergen, R; Escobar, GJ; Folck, BF; Gardner, MN; Li, DK; Verdi, JE; Xiong, B | 1 |
Domarecki, A; Godula-Stuglik, U; Mazur, B; Stojewska, M | 1 |
Alkharfy, KM; Frye, RF; Kellum, JA; Matzke, GR | 1 |
Chamberland, S; Cho, A; Dudley, MN; Glinka, TW; Griffith, D; Hecker, SJ; Huie, K; Lee, VJ; Ludwikow, M; Zhang, ZJ | 1 |
Angehrn, P; Hebeisen, P; Heinze-Krauss, I; Hohl, P; Page, MG; Then, RL | 1 |
Kan'ovska, E; Khitsova, S; Rosmanova, R; Sredkova, M; V'lkova, A | 1 |
Bhattacharjee, AK; Cross, AS; Glaser, K; Opal, SM; Palardy, JE; Parejo, NA; Warren, HS | 1 |
Gin, T; Gomersall, CD; Joynt, GM; Lipman, J; Wong, EL; Young, RJ | 1 |
Aguilar, L; Alkorta, M; Giménez, MJ; Pérez-Trallero, E; Vicente, D | 1 |
Fraenkel, D; Lipman, J; Rickard, CM; Wallis, SC | 1 |
Morrison, DC; Opal, SM; Palardy, JE; Parejo, N | 1 |
Barratt, A; Berry, A | 1 |
Oh, HM; Tan, AL | 1 |
Badolati, A; Fontán, PA; Gammella, D; Maskin, B; Spinedi, EG | 1 |
Colizza, S; Rossi, S | 1 |
Eu, KW; Maw, A; Seow-Choen, F | 1 |
Hameed, R; Riordan, FA | 1 |
Avery, GS; Brogden, RN; Heel, RC; Speight, TM | 1 |
Eller, JJ; Macias, EG | 1 |
Butzler, JP; Clumeck, N; Vanhoof, R; Vanlaethem, Y | 1 |
Chico Rizzo, E | 1 |
Fereres, J | 1 |
Balcke, P; Graninger, W; Kopsa, H; Pils, P; Schimatzek, A; Schmidt, P; Zazgornik, J | 1 |
McCloskey, RV | 1 |
Gentry, LO | 1 |
Billiard, BS; Freimer, EH; Ribner, BS | 1 |
Benzer, H; Coraim, F; Koller, W; Lackner, F; Pichler, H; Rotter, M; Stanek, G | 1 |
Berman, E; Santella, PJ; Tanrisever, B | 1 |
Goldberger, MJ; Neu, HC; Parry, MF | 1 |
Hitzenberger, G | 1 |
Hiromatsu, K; Kotani, Y; Nishimura, T; Tabuki, K; Takashima, T | 1 |
Anderson, ET; Hewitt, WL; Young, LS | 1 |
Bernfeld, GE; Caloza, DL; Semar, RW | 1 |
Adam, D | 1 |
Lantz, B; Reizenstein, P | 1 |
Bodey, GP; Ketchel, S; Rodriguez, V | 1 |
Cobbs, CG; Holley, HP; Reymann, MT | 1 |
Bourque, G; Charrel, CT; Gouin, F; Morel, M; Pedrant, G; Seguin, F | 1 |
Gorbach, SL; Tally, FP | 1 |
Bartlett, JG; Chow, AW; Finegold, SM; Flora, DJ; Gorbach, SL; Harder, EJ; Tally, FP | 1 |
Kirby, WM | 1 |
Crossley, K; Iannini, PB | 1 |
Hasuike, T; Hirai, M; Inoue, T; Misu, K; Nakao, Y; Ohira, H; Ota, K; Tanaka, K; Yamane, T; Yasui, Y | 1 |
Sotoyama, K | 1 |
Angehrn, P; Hohl, P; Hubschwerlen, C; Page, M; Then, R | 1 |
Adam, F; Isert, D; Klesel, N; Limbert, M; Markus, A; Schrinner, E; Seibert, G | 1 |
Akasaka, K; Furukawa, Y; Im, T; Inoue, K; Kageyama, T; Nasu, K; Ohyabu, H; Sannomiya, Y; Tatsumi, N; Yonezawa, T | 1 |
Abei, T | 1 |
Ng, TL; Wong, SN | 1 |
Chow, JW; Fine, MJ; Hooper, DC; Johnson, MP; Miyashiro, DK; Quinn, JP; Ramphal, R; Shlaes, DM; Wagener, MM; Yu, VL | 1 |
Angehrn, P; Arisawa, M; Sekine, Y; Shimizu, S; Takano, H; Then, RL | 1 |
Adachi, K; Hatakeyama, T; Inamatsu, T; Kodaira, M; Masuda, Y; Nakajima, T; Sakamoto, H | 1 |
Isert, D; Klesel, N; Limbert, M; Markus, A; Schrinner, E; Seeger, K; Seibert, G | 1 |
Zach, TL | 1 |
Burman, LG; Lundström, G; Olsson-Liljequist, B; Tullus, K | 1 |
Aguado, JM; Alsar, MJ; Baro, J; Conde, E; Garijo, J; Gómez Casares, MT; Iriondo, A; Muruzábal, MJ; Pérez, M; Richard, C | 1 |
Bale, MJ; Doebbeling, BN; Pfaller, MA; Wenzel, RP | 1 |
Dowd, PM; Robinson, TW; Rustin, MH | 1 |
Bayer, AS; Nelson, RJ; Slama, TG | 1 |
Gökalp, AS; Oğuz, A | 1 |
Duff, P; Dunlow, S | 1 |
Isert, D; Klesel, N; Limbert, M; Markus, A; Schrinner, E; Seibert, G | 1 |
Akaoka, I; Kunii, O; Minoda, S; Miyashita, H; Ono, Y; Yamanouchi, T | 1 |
Gaston, MA | 1 |
Füssle, R; Lang, U; Wurdinger, T | 1 |
Jaspers, MT; Little, JW | 1 |
Cioffi, GA; Taybos, GM; Terezhalmy, GT | 1 |
Brunel, D; Guenounou, M; Nauciel, C; Outin, HD; Paul, G; Philippon, A; Pilliot, J; Ronco, E | 1 |
Cheng, DL; Fung, CP; Juang, YC; Liu, CY; Wang, LS | 1 |
Eidelman, AI; Isacsohn, M; Schimmel, MS; Wilschanski, MA | 1 |
Kim, KS | 1 |
Grabe, M | 1 |
Hirschmann, JV | 1 |
Ganzinger, U; Grimm, G; Haslberger, A; Kleinberger, G; Laggner, A; Lenz, K; Martindale, JJ; Millendorfer, A; Schatz, F | 1 |
Karran, SJ; Lowes, JA; Saddler, B; Scott, SD | 1 |
Greig, J; Gunn, R; Haddock, G; Mason, B; McArdle, C; Morran, C; Sleigh, D | 1 |
Funada, H; Machi, T; Matsuda, T | 1 |
Arpi, M; Frimodt-Møller, N; Hønberg, PZ | 1 |
Cherubin, CE; Eng, RH; Goldstein, EJ; Smith, SM | 1 |
Alexopoulos, E; Anassis, P; Hadjidimitriou, C; Papadimitriou, M | 1 |
Bustamante, CI; Johnson, DE; Wade, JC | 1 |
Nichols, RL | 1 |
Fleer, A; Geelen, SP; Neeleman, C; Roord, JJ | 1 |
Ganzinger, U; Haslberger, AG; Millendorfer, A; Reiter, H; Schiel, H | 1 |
Gray, JL; Medoff, G; Smith, MD; Woodward, RS | 1 |
Ganzinger, U; Haslberger, A; Omilian-Rosso, R; Schiel, H; Schütze, E | 1 |
Fujii, R; Nishimura, T | 2 |
Barson, WJ; Brady, MT; Hribar, MM; Marcon, MJ; Miller, MA; Pacini, DL; Powell, DA | 1 |
Starr, SE | 1 |
Bayer, AS; Kim, KS | 1 |
Ward, TT | 1 |
Guenthner, SH; Norris, SM; Wenzel, RP | 1 |
Massam, M; Towner, KJ | 1 |
Barrall, DT; Burchard, KW; Kenney, PR; Slotman, GJ | 1 |
Young, LS | 1 |
Ganzinger, U; Haslberger, A | 1 |
Gierhake, FW | 1 |
Noone, P; Pattison, JR | 1 |
Guckian, JC; Kier, CM; Reinarz, JA | 1 |
Darrell, JH | 1 |
Bodey, GP; Horikoshi, N; Rodriguez, V; Valdivieso, M | 1 |
Garfield-Davies, D; Hughes, K; Noone, P; Parsons, TM; Pattison, JR; Slack, RC | 1 |
Finland, M; McCall, CE; Reed, CW; Steigbigel, NH | 1 |
Bernadou, A; Bilski-Pasquier, G; Bousser, J; Dao, C; Gerbal, R; Zittoun, R | 1 |
Eichenwald, HF | 1 |
von Perjés, OC | 1 |
Hodson, AH; Holloway, WJ | 3 |
Seftel, HC | 1 |
Austin, TW; Wallace, JF | 1 |
Gordon, A | 1 |
Sanford, JP | 2 |
Minagawa, M; Miyoshi, K; Seiga, K; Yamaji, K | 1 |
Watson, CE | 1 |
Steinitz, H | 1 |
McGuire, EJ | 1 |
Haschek, H; Porpaczy, P; Schmidt, W | 1 |
Del Bene, VE; Farrar, WE | 1 |
Bodey, GP; Inagaki, J | 1 |
Acar, JF; Bastin, R; Worms, R | 1 |
von Oldershausen, HF | 1 |
Bailey, A; Hadley, A; James, DG; Walker, A | 1 |
Acar, JF; Chabbert, YA; Courvalin, P | 1 |
Mössner, G | 1 |
Lüthy, R; Siegenthaler, G; Siegenthaler, W; Vetter, H | 1 |
Marget, W | 1 |
Plotkin, SA | 1 |
MacMillan, MG | 1 |
Klare, B; Müller, G | 1 |
Monnier, C; Moskovtchenko, JF; Traeger, J; Zech, P | 1 |
Ross, S | 1 |
Buluk, H; Chyrek-Borowska, S; Kiersnowska, B; Lukjan, H | 1 |
Fass, RJ; Perkins, RL; Saslaw, S | 1 |
Stratford, BC | 1 |
Braunstein, H; Gibson, BC; Tucker, E | 1 |
Fekety, FR; Geddes, AM; Ohkoshi, M; Turck, M | 1 |
Benner, EJ | 1 |
Stewart, GT | 1 |
Ruedy, J | 1 |
47 review(s) available for cephalosporin c and Blood Poisoning
Article | Year |
---|---|
Efficacy of empiric antibiotic treatment of late-onset neonatal sepsis caused by Enterobacteriaceae: A systematic review.
Topics: Ampicillin; Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae; Escherichia coli; Gentamicins; Humans; Infant, Newborn; Microbial Sensitivity Tests; Neonatal Sepsis; Sepsis | 2022 |
Topics: Acetogenins; Acute Disease; Acute Kidney Injury; Administration, Intravenous; Aged; Albumins; Alcoholism; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; alpha-Glucosidases; Anemia; Animals; Anthozoa; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Antigens, Bacterial; Antihypertensive Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Ascites; Asthma; Bacteria; beta-Lactamases; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Binding Sites; Biological Availability; Biomass; Borderline Personality Disorder; Brain; Brucella abortus; Brucella melitensis; Brucellosis; Calcium; Carbapenems; Case-Control Studies; Caseins; Cattle; CD8-Positive T-Lymphocytes; Ceftaroline; Cell Line; Cell Line, Tumor; Cell Physiological Phenomena; Cell Proliferation; Cephalosporins; Chemotherapy, Adjuvant; China; Chitin; Chlorella; Chlorophyll; Chlorophyll A; Chlorophyta; Cholangiocarcinoma; Cisplatin; Conotoxins; Contrast Media; Conus Snail; Cross-Sectional Studies; Cytokines; Decapodiformes; Deoxycytidine; Diagnostic and Statistical Manual of Mental Disorders; Dietary Fiber; Diterpenes; DNA Methylation; Dogs; Double-Blind Method; Drug Design; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; Eicosapentaenoic Acid; Enzyme-Linked Immunosorbent Assay; Epidermis; Escherichia coli; Escherichia coli Infections; Extraintestinal Pathogenic Escherichia coli; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Volatile; Feasibility Studies; Feces; Female; Ferritins; Fluorodeoxyglucose F18; Gastrectomy; Gastrointestinal Microbiome; Gemcitabine; Glomerular Filtration Rate; Glucose; Glycerol; Granulocyte-Macrophage Colony-Stimulating Factor; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Immunoassay; Immunoglobulin G; India; Infant, Newborn; Infertility; Inflammation; Intensive Care Units; Iron; Iron Deficiencies; Kidney; Lacticaseibacillus rhamnosus; Laurencia; Leukocytes; Lipids; Liver Cirrhosis; Long Interspersed Nucleotide Elements; Longitudinal Studies; Male; Mesenchymal Stem Cells; Methicillin-Resistant Staphylococcus aureus; Mice; Microalgae; Microbial Sensitivity Tests; Microscopy; Middle Aged; Minerals; Molecular Conformation; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Myeloid Cells; Myeloid-Derived Suppressor Cells; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nephropidae; Nicotinic Antagonists; Nitrogen; Obesity; Oxaliplatin; Paclitaxel; Panax; Pancreatic Neoplasms; Pancreatitis; Personality; Personality Disorders; Personality Inventory; Photobioreactors; Plant Extracts; Plasmalogens; Plasmids; Polymorphism, Genetic; Polynesia; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prebiotics; Predictive Value of Tests; Prognosis; Prolyl-Hydroxylase Inhibitors; Rabbits; Radiopharmaceuticals; Rats; Rats, Wistar; Receptors, Nicotinic; Recombinant Proteins; Retrospective Studies; Rifampin; Risk Factors; RNA, Ribosomal, 16S; Salinity; Seaweed; Sensitivity and Specificity; Sepsis; Sesquiterpenes; Severity of Illness Index; Shock, Septic; Silicones; Single Photon Emission Computed Tomography Computed Tomography; Skin; Snails; Solubility; Solvents; Sputum; Staphylococcal Infections; Stomach Neoplasms; Stramenopiles; Structure-Activity Relationship; Technetium Tc 99m Exametazime; Technology; Terpenes; Tuberculosis; Tuberculosis, Multidrug-Resistant; Urinary Catheters; Urinary Tract Infections; Vascular Endothelial Growth Factor A; Virulence Factors; Water; Wound Healing | 2023 |
Prevalence and outcome of bloodstream infections due to third-generation cephalosporin-resistant Enterobacteriaceae in sub-Saharan Africa: a systematic review.
Topics: Africa South of the Sahara; Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae Infections; Escherichia coli; Humans; Prevalence; Sepsis | 2020 |
Treatment of extended-spectrum β-lactamases infections: what is the current role of new β-lactams/β-lactamase inhibitors?
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Ceftaroline; Ceftazidime; Cephalosporins; Cyclooctanes; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Public Health; Sepsis; Tazobactam | 2020 |
Current Clinical Trials on the Use of Ceftaroline in the Pediatric Population.
Topics: Adult; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Child; Community-Acquired Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Sepsis; Streptococcus pneumoniae | 2017 |
Antibiotic Dosing in Continuous Renal Replacement Therapy.
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Computer Simulation; Critical Illness; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Monte Carlo Method; Penicillanic Acid; Piperacillin; Renal Replacement Therapy; Sepsis; Tazobactam; Thienamycins | 2017 |
[The 2018 Update of the Recommendations of the Paul-Ehrlich-Society for Chemotherapy on the Initial Parenteral Therapy of Bacterial Diseases in Adults - What's relevant for Intensive Care?]
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Critical Care; Critical Illness; Humans; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Bacterial; Practice Guidelines as Topic; Sepsis; Staphylococcal Infections | 2019 |
Extended or continuous versus short-term intravenous infusion of cephalosporins: a meta-analysis.
Topics: Anti-Bacterial Agents; Cephalosporins; Databases, Bibliographic; Drug Administration Schedule; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infusions, Intravenous; Pneumonia; Risk Factors; Sepsis; Treatment Outcome | 2013 |
Escherichia coli sequence type 131: epidemiology and challenges in treatment.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Cystitis; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; United States | 2014 |
Febrile urinary tract infections: pyelonephritis and urosepsis.
Topics: Anti-Infective Agents, Urinary; Cephalosporins; Diabetes Complications; Fever; Humans; Immunocompromised Host; Levofloxacin; Penicillanic Acid; Pyelonephritis; Randomized Controlled Trials as Topic; Risk Factors; Sepsis; Tazobactam; Treatment Outcome; Urinary Tract Infections | 2016 |
Meningococcemia in Adults: A Review of the Literature.
Topics: Adult; Africa; Anti-Bacterial Agents; Cephalosporins; Child; Chloramphenicol; Disease Outbreaks; Disseminated Intravascular Coagulation; Drug Resistance, Bacterial; Host-Pathogen Interactions; Humans; Meningococcal Infections; Neisseria meningitidis; Osteonecrosis; Penicillin G; Sepsis; Vaccines, Conjugate | 2016 |
Cholestasis in Preterm Infants.
Topics: Anti-Bacterial Agents; Antifungal Agents; Cephalosporins; Cholestasis; Enteral Nutrition; Enterocolitis, Necrotizing; Fat Emulsions, Intravenous; Fluconazole; Gastrointestinal Diseases; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Parenteral Nutrition; Risk Factors; Sepsis; Severity of Illness Index | 2016 |
[Urinary tract infections: cystitis, pyelonephritis, urosepsis].
Topics: Anti-Infective Agents, Urinary; Bacteriuria; Cephalosporins; Chronic Disease; Cystitis; Drug Resistance, Bacterial; Fluoroquinolones; Fosfomycin; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Pyelonephritis; Recurrence; Risk Factors; Sepsis; Tromethamine; Urinary Tract Infections | 2012 |
[Klebsiella infection].
Topics: 4-Quinolones; Anti-Infective Agents; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Penicillinase; Respiratory Tract Infections; Sepsis; Urinary Tract Infections | 2003 |
[Pseudomonas aeruginosa infection].
Topics: 4-Quinolones; Anti-Infective Agents; Bacteremia; Biofilms; Carbapenems; Cephalosporins; Fimbriae, Bacterial; Flagella; Humans; Immunocompromised Host; Multidrug Resistance-Associated Proteins; Prognosis; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Sepsis; Trans-Activators; Urinary Tract Infections | 2003 |
Pasteurella multocida sepsis, due to a scratch from a pet cat, in a post-chemotherapy neutropenic patient with non-Hodgkin lymphoma.
Topics: Aged; Animals; Animals, Domestic; Anti-Bacterial Agents; Anticoagulants; Bites and Stings; Cats; Cefepime; Cephalosporins; Chondroitin Sulfates; Dermatan Sulfate; Female; Granulocyte Colony-Stimulating Factor; Heparitin Sulfate; Humans; Lymphoma, Non-Hodgkin; Neutropenia; Pasteurella Infections; Pasteurella multocida; Sepsis | 2007 |
[Antibacterial therapy of intraabdominal infection. Third generation cephalosporins].
Topics: Abdomen; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Cephalosporins; Humans; Peritonitis; Sepsis | 2006 |
The cephalosporin compounds in severe neonatal infection.
Topics: Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Enterobacteriaceae Infections; Humans; Infant, Newborn; Meningitis; Moxalactam; Sepsis | 1984 |
The use of beta-lactam antibiotics in the treatment of septicaemia and endocarditis.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Cephalosporins; Endocarditis, Bacterial; Humans; Penicillin G; Penicillin V; Penicillinase; Penicillins; Sepsis | 1984 |
The new beta-lactamase-stable cephalosporins.
Topics: Bacterial Infections; beta-Lactamases; Central Nervous System Diseases; Cephalosporins; Chemical Phenomena; Chemistry; Endocarditis, Bacterial; Enterobacteriaceae; Pseudomonas aeruginosa; Respiratory Tract Infections; Sepsis; Streptococcus; Surgical Wound Infection; Urinary Tract Infections | 1982 |
Bacterial endocarditis: a review.
Topics: Animals; Cat Diseases; Cats; Cephalosporins; Dog Diseases; Dogs; Electrocardiography; Endocarditis, Bacterial; Penicillins; Physical Examination; Sepsis | 1980 |
[Yersinia enterocolitica infections].
Topics: Anemia, Hemolytic; Anti-Bacterial Agents; Arthritis; Arthritis, Reactive; Cephalosporins; Erythema Nodosum; Gastroenteritis; Glomerulonephritis; Humans; Liver Abscess; Sepsis; Sulfonamides; Thyroid Diseases; Yersinia Infections | 1981 |
[Febrile neutropenia: empiric antibiotic therapy from 1975 to 1997].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Meropenem; Neutropenia; Sepsis; Thienamycins | 1997 |
[Vibrio vulnificus infections].
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Risk Factors; Seasons; Sepsis; Skin Diseases, Bacterial; Tetracyclines; Vibrio; Vibrio Infections | 1998 |
Cephalosporins.
Topics: Cephalosporins; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Meningitis, Bacterial; Sepsis | 1998 |
Pharmacologic considerations in the treatment of neonatal septicemia and its complications.
Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidiarrheals; Cephalosporins; Histamine H2 Antagonists; Horse Diseases; Horses; Hypnotics and Sedatives; Sepsis; Sulfonamides | 1999 |
Prophylactic antibiotic use in transurethral prostatic resection: a meta-analysis.
Topics: Antibiotic Prophylaxis; Bacteriuria; Cephalosporins; Humans; Male; Postoperative Complications; Randomized Controlled Trials as Topic; Sepsis; Transurethral Resection of Prostate | 2002 |
Shigella septicaemia in adults: report of two cases and mini-review.
Topics: Ceftriaxone; Cephalosporins; Diarrhea; Female; Humans; Middle Aged; Neutropenia; Renal Insufficiency; Risk Factors; Sepsis; Shigella flexneri; Thrombocytopenia | 2001 |
Antibiotic prophylaxis and treatment of surgical abdominal sepsis.
Topics: Abdomen; Antibiotic Prophylaxis; Cephalosporins; Humans; Randomized Controlled Trials as Topic; Sepsis; Surgical Procedures, Operative; Surgical Wound Infection | 2001 |
Cefuroxime: a review of its antibacterial activity, pharmacological properties and therapeutic use.
Topics: Adult; Bacteria; Cephalosporins; Child; Drug Resistance, Microbial; Female; Furans; Gonorrhea; Humans; Hydrogen-Ion Concentration; Infant, Newborn; Kinetics; Osteomyelitis; Pregnancy; Probenecid; Respiratory Tract Infections; Sepsis; Surgical Wound Infection; Tissue Distribution; Urinary Tract Infections | 1979 |
Antibiotics in surgery.
Topics: Anti-Bacterial Agents; Bacterial Infections; Biliary Tract Diseases; Burns; Catheterization; Cephalosporins; Clindamycin; Colon; Cross Infection; Drug Combinations; Drug Therapy, Combination; Female; Genital Diseases, Female; Gentamicins; Humans; Liver Abscess; Penicillin Resistance; Penicillins; Peritonitis; Postoperative Complications; Sepsis; Sulfamethoxazole; Surgical Procedures, Operative; Tetracyclines; Trimethoprim | 1975 |
Haemophilus influenzae septicaemia in the neonate: report of two cases and review of the English literature.
Topics: Birth Weight; Cephalosporins; Female; Gestational Age; Haemophilus Infections; Haemophilus influenzae; Humans; Infant, Newborn; Male; Sepsis | 1991 |
Current concepts in prevention of prosthetic valve endocarditis.
Topics: Animals; Cephalosporins; Endocarditis, Bacterial; Heart Valve Prosthesis; Humans; Premedication; Sepsis; Vancomycin | 1990 |
Enterobacter: an emerging nosocomial pathogen.
Topics: Bacteriophage Typing; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Humans; Sepsis; Serotyping | 1988 |
Total joint replacement: a consideration for antimicrobial prophylaxis.
Topics: Anti-Bacterial Agents; Cephalosporins; Dental Care for Disabled; Humans; Joint Prosthesis; Sepsis; Staphylococcal Infections; Surgical Wound Infection | 1988 |
Antimicrobial agents in transurethral prostatic resection.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Drug Combinations; Humans; Male; Penicillins; Premedication; Prostatectomy; Risk; Sepsis; Sulfamethoxazole; Surgical Wound Infection; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1987 |
Controversies in antimicrobial prophylaxis.
Topics: Animals; Anti-Bacterial Agents; Blood Vessel Prosthesis; Cephalosporins; Colon; Drug Administration Schedule; Humans; Joint Prosthesis; Premedication; Rectum; Sepsis; Surgical Wound Infection | 1987 |
Monotherapy for empiric treatment of fever in granulocytopenic cancer patients.
Topics: Agranulocytosis; Animals; Anti-Bacterial Agents; Bacterial Infections; Blood Bactericidal Activity; Cephalosporins; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Fever; Gram-Negative Bacteria; Humans; Neoplasms; Penicillins; Pseudomonas Infections; Sepsis; Thienamycins | 1986 |
Management of intra-abdominal sepsis.
Topics: Abdomen, Acute; Abdominal Injuries; Abscess; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Clinical Trials as Topic; Drainage; Drug Therapy, Combination; Humans; Peritonitis; Risk; Sepsis; Wounds, Penetrating | 1986 |
Antimicrobial therapy of bacterial sepsis in the newborn infant.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Aztreonam; Bacteria; Cephalosporins; Cross Infection; Drug Therapy, Combination; Humans; Imipenem; Infant Mortality; Infant, Newborn; Penicillin Resistance; Penicillins; Sepsis; Thienamycins | 1985 |
Postoperative infection in urologic surgery.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Bacteriuria; Catheters, Indwelling; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Female; Humans; Male; Microbial Sensitivity Tests; Postoperative Complications; Prostate; Prostatectomy; Pyuria; Risk; Sepsis; Time Factors; Urinary Catheterization; Urinary Tract Infections; Urologic Diseases | 1985 |
Antimicrobial therapy in children.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacitracin; Carbenicillin; Cephalosporins; Child; Child, Preschool; Chloramphenicol; Clindamycin; Erythromycin; Female; Humans; Infant; Infant, Newborn; Lincomycin; Male; Meningitis; Nalidixic Acid; Nitrofurans; Penicillin G; Polymyxins; Rifampin; Sepsis; Sulfonamides; Tetracycline; Trimethoprim | 1974 |
Antimicrobial therapy of infections due to anaerobic bacteria.
Topics: Abortion, Septic; Abscess; Aminoglycosides; Anaerobiosis; Anti-Bacterial Agents; Bacterial Infections; Brain Abscess; Cephalosporins; Chloramphenicol; Clindamycin; Endocarditis, Bacterial; Erythromycin; Female; Humans; Lincomycin; Lung Abscess; Penicillins; Pregnancy; Sepsis; Tetracycline | 1972 |
[Actual problems in clinical chemotherapy].
Topics: Anti-Bacterial Agents; Antitubercular Agents; Cephalosporins; Endocarditis, Bacterial; Enteritis; Gentamicins; Humans; Infections; Lincomycin; Meningitis; Penicillins; Rifampin; Sepsis; Staphylococcal Infections; Streptococcal Infections; Sulfonamides; Urinary Tract Infections; Vancomycin | 1967 |
Cephalexin--a new oral antibiotic.
Topics: Animals; Cephalosporins; Gonorrhea; Humans; Penicillinase; Respiratory Tract Infections; Sepsis; Staphylococcal Infections; Staphylococcus; Urinary Tract Infections | 1970 |
[Basic principles of effective antibiotic therapy].
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Biliary Tract Diseases; Carbenicillin; Cephalosporins; Chloramphenicol; Colistin; Endocarditis, Subacute Bacterial; Gentamicins; Humans; Meningitis; Osteomyelitis; Oxacillin; Sepsis; Tetracycline; Urinary Tract Infections | 1971 |
[Clinical picture and antibiotic therapy of bacterial septicemias in internal medicine].
Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Chloramphenicol; Drug Combinations; Endocarditis, Bacterial; Enterobacter; Escherichia coli Infections; Germany, West; Humans; Klebsiella Infections; Penicillins; Proteus Infections; Pseudomonas Infections; Sepsis; Staphylococcal Infections | 1971 |
57 trial(s) available for cephalosporin c and Blood Poisoning
Article | Year |
---|---|
Investigator-Driven Randomised Controlled Trial of Cefiderocol versus Standard Therapy for Healthcare-Associated and Hospital-Acquired Gram-negative Bloodstream Infection: Study protocol (the GAME CHANGER trial): study protocol for an open-label, randomis
Topics: Adult; Anti-Bacterial Agents; Cefiderocol; Cephalosporins; Delivery of Health Care; Gram-Negative Bacterial Infections; Hospitals; Humans; Microbial Sensitivity Tests; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Sepsis; Standard of Care | 2021 |
Topics: Acetogenins; Acute Disease; Acute Kidney Injury; Administration, Intravenous; Aged; Albumins; Alcoholism; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; alpha-Glucosidases; Anemia; Animals; Anthozoa; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Antigens, Bacterial; Antihypertensive Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Ascites; Asthma; Bacteria; beta-Lactamases; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Binding Sites; Biological Availability; Biomass; Borderline Personality Disorder; Brain; Brucella abortus; Brucella melitensis; Brucellosis; Calcium; Carbapenems; Case-Control Studies; Caseins; Cattle; CD8-Positive T-Lymphocytes; Ceftaroline; Cell Line; Cell Line, Tumor; Cell Physiological Phenomena; Cell Proliferation; Cephalosporins; Chemotherapy, Adjuvant; China; Chitin; Chlorella; Chlorophyll; Chlorophyll A; Chlorophyta; Cholangiocarcinoma; Cisplatin; Conotoxins; Contrast Media; Conus Snail; Cross-Sectional Studies; Cytokines; Decapodiformes; Deoxycytidine; Diagnostic and Statistical Manual of Mental Disorders; Dietary Fiber; Diterpenes; DNA Methylation; Dogs; Double-Blind Method; Drug Design; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; Eicosapentaenoic Acid; Enzyme-Linked Immunosorbent Assay; Epidermis; Escherichia coli; Escherichia coli Infections; Extraintestinal Pathogenic Escherichia coli; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Volatile; Feasibility Studies; Feces; Female; Ferritins; Fluorodeoxyglucose F18; Gastrectomy; Gastrointestinal Microbiome; Gemcitabine; Glomerular Filtration Rate; Glucose; Glycerol; Granulocyte-Macrophage Colony-Stimulating Factor; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Immunoassay; Immunoglobulin G; India; Infant, Newborn; Infertility; Inflammation; Intensive Care Units; Iron; Iron Deficiencies; Kidney; Lacticaseibacillus rhamnosus; Laurencia; Leukocytes; Lipids; Liver Cirrhosis; Long Interspersed Nucleotide Elements; Longitudinal Studies; Male; Mesenchymal Stem Cells; Methicillin-Resistant Staphylococcus aureus; Mice; Microalgae; Microbial Sensitivity Tests; Microscopy; Middle Aged; Minerals; Molecular Conformation; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Myeloid Cells; Myeloid-Derived Suppressor Cells; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nephropidae; Nicotinic Antagonists; Nitrogen; Obesity; Oxaliplatin; Paclitaxel; Panax; Pancreatic Neoplasms; Pancreatitis; Personality; Personality Disorders; Personality Inventory; Photobioreactors; Plant Extracts; Plasmalogens; Plasmids; Polymorphism, Genetic; Polynesia; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prebiotics; Predictive Value of Tests; Prognosis; Prolyl-Hydroxylase Inhibitors; Rabbits; Radiopharmaceuticals; Rats; Rats, Wistar; Receptors, Nicotinic; Recombinant Proteins; Retrospective Studies; Rifampin; Risk Factors; RNA, Ribosomal, 16S; Salinity; Seaweed; Sensitivity and Specificity; Sepsis; Sesquiterpenes; Severity of Illness Index; Shock, Septic; Silicones; Single Photon Emission Computed Tomography Computed Tomography; Skin; Snails; Solubility; Solvents; Sputum; Staphylococcal Infections; Stomach Neoplasms; Stramenopiles; Structure-Activity Relationship; Technetium Tc 99m Exametazime; Technology; Terpenes; Tuberculosis; Tuberculosis, Multidrug-Resistant; Urinary Catheters; Urinary Tract Infections; Vascular Endothelial Growth Factor A; Virulence Factors; Water; Wound Healing | 2023 |
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cefiderocol; Cephalosporins; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Pneumonia, Bacterial; Sepsis; Urinary Tract Infections; Young Adult | 2021 |
Piperacillin-tazobactam versus meropenem for treatment of bloodstream infections caused by third-generation cephalosporin-resistant Enterobacteriaceae: a study protocol for a non-inferiority open-label randomised controlled trial (PeterPen).
Topics: Anti-Bacterial Agents; beta-Lactamases; Canada; Cephalosporins; Enterobacteriaceae; Humans; Israel; Italy; Meropenem; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Retrospective Studies; Sepsis | 2021 |
Ceftolozane-tazobactam versus meropenem for definitive treatment of bloodstream infection due to extended-spectrum beta-lactamase (ESBL) and AmpC-producing Enterobacterales ("MERINO-3"): study protocol for a multicentre, open-label randomised non-inferior
Topics: Adult; Anti-Bacterial Agents; Australia; beta-Lactamases; Cephalosporins; Clostridioides difficile; Escherichia coli; Humans; Italy; Lebanon; Meropenem; Microbial Sensitivity Tests; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Saudi Arabia; Sepsis; Singapore; Spain; Tazobactam | 2021 |
Antibiotic use practice and predictors of hospital outcome among patients with systemic bacterial infection: Identifying targets for antibiotic and health care resource stewardship.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Female; Health Resources; Humans; Length of Stay; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Sepsis; Vancomycin | 2019 |
[Application of preparation quadrocef in the treatment of surgical sepsis].
Topics: Adult; Aged; Anti-Bacterial Agents; APACHE; Cefepime; Cephalosporins; Digestive System Diseases; Female; Humans; Male; Middle Aged; Peritonitis; Postoperative Complications; Sepsis; Treatment Outcome | 2011 |
Cephalosporins periprostatic injection: are really effective on infections following prostate biopsy?
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy, Needle; Cephalosporins; Double-Blind Method; Follow-Up Studies; Humans; Injections; Male; Middle Aged; Prospective Studies; Prostate; Prostatitis; Sepsis; Treatment Outcome | 2012 |
Population pharmacokinetics of four β-lactams in critically ill septic patients comedicated with amikacin.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Amikacin; Anti-Bacterial Agents; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Critical Illness; Drug Monitoring; Female; Humans; Male; Meropenem; Metabolic Clearance Rate; Middle Aged; Models, Biological; Piperacillin; Sepsis; Thienamycins; Tissue Distribution; Treatment Outcome | 2012 |
A multicenter comparative study of cefepime versus broad-spectrum antibacterial therapy in moderate and severe bacterial infections.
Topics: Abdominal Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Cefepime; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Peritonitis; Pneumonia, Bacterial; Prospective Studies; Sepsis; Severity of Illness Index; South America; Treatment Outcome; Urinary Tract Infections | 2002 |
Coverage of enterococci in community acquired secondary peritonitis: results of a randomized trial.
Topics: Adult; Aged; Cephalosporins; Community-Acquired Infections; Digestive System Surgical Procedures; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Penicillins; Peritonitis; Postoperative Complications; Prospective Studies; Reoperation; Sepsis; Surgical Wound Infection | 2000 |
Outcomes of patients with melioidosis treated with meropenem.
Topics: Adolescent; Adult; Aged; Ceftazidime; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Male; Melioidosis; Meropenem; Middle Aged; Prospective Studies; Sepsis; Thienamycins; Treatment Outcome | 2004 |
Comparative effects of ciprofloxacin and ceftazidime on cytokine production in patients with severe sepsis caused by gram-negative bacteria.
Topics: Adult; Aged; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Cytokines; Female; Gram-Negative Bacterial Infections; Humans; Interleukins; Male; Middle Aged; Sepsis; Treatment Outcome; Tumor Necrosis Factor-alpha | 2004 |
Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections.
Topics: Aged; Anti-Bacterial Agents; APACHE; Area Under Curve; Bacteremia; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Endpoint Determination; Escherichia coli; Female; Humans; Klebsiella; Male; Microbial Sensitivity Tests; Predictive Value of Tests; Pseudomonas aeruginosa; Renal Insufficiency; Sepsis; Treatment Outcome | 2008 |
Ceftazidime in clinical practice.
Topics: Adult; Aged; Bacterial Infections; Ceftazidime; Cephalosporins; Clinical Trials as Topic; Drug Eruptions; Female; Humans; Male; Middle Aged; Osteitis; Respiratory Tract Infections; Sepsis; Skin Diseases, Infectious; Sweden; Thrombophlebitis; Urinary Tract Infections | 1983 |
Ceftazidime in severe infections: a Swiss multicentre study.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Biliary Tract Diseases; Ceftazidime; Cephalosporins; Clinical Trials as Topic; Diarrhea; Drug Eruptions; Female; Humans; Liver Function Tests; Male; Middle Aged; Osteoarthritis; Otitis Externa; Respiratory Tract Infections; Sepsis; Skin Diseases, Infectious; Switzerland; Thrombophlebitis; Urinary Tract Infections | 1983 |
Cefotaxime--a clinical study.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefotaxime; Cephalosporins; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Sepsis; Urinary Tract Infections | 1981 |
Ceftizoxime therapy of infections in hospitalized patients and comparison with cefamandole for urinary tract infections.
Topics: Adult; Aged; Cefamandole; Cefotaxime; Ceftizoxime; Cephalosporins; Female; Hospitalization; Humans; Male; Middle Aged; Pneumonia; Pyelonephritis; Random Allocation; Sepsis; Urinary Tract Infections | 1982 |
[Septicemia and focal infection. Efficacy of moxalactam. Results of the cooperative study conducted in France].
Topics: Adult; Bacterial Infections; Cephalosporins; Cephamycins; Clinical Trials as Topic; Escherichia coli Infections; Female; Focal Infection; France; Humans; Male; Moxalactam; Sepsis | 1983 |
[Clinical evaluation of moxalactam].
Topics: Bacterial Infections; Cephalosporins; Cephamycins; Clinical Trials as Topic; Critical Care; Cross Infection; Humans; Meningitis; Moxalactam; Sepsis; Urinary Tract Infections | 1983 |
[Clinical evaluation of T-1982 (cefbuperazone) in the pediatric infections].
Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Clinical Trials as Topic; Female; Half-Life; Humans; Infant; Male; Respiratory Tract Infections; Sepsis | 1983 |
Clinical trials with cefoperazone in the field of internal medicine in Japan.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Biliary Tract Diseases; Cefoperazone; Cephalosporins; Clinical Trials as Topic; Female; Humans; Liver Diseases; Male; Middle Aged; Respiratory Tract Infections; Sepsis; Urinary Tract Infections | 1980 |
Clinical evaluation of moxalactam.
Topics: Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Clinical Trials as Topic; Drug Resistance, Microbial; Female; Humans; Infant; Infant, Newborn; Male; Middle Aged; Moxalactam; Pneumonia; Sepsis | 1981 |
[Perioperative antibiotic prophylaxis in elective splenectomy. A randomized prospective study].
Topics: Adult; Cefuroxime; Cephalosporins; Humans; Male; Middle Aged; Pneumonia; Postoperative Complications; Premedication; Prospective Studies; Random Allocation; Sepsis; Splenectomy; Surgical Wound Infection; Urinary Tract Infections | 1984 |
Therapy of staphylococcal infections with cefamandole or vancomycin alone or with a combination of cefamandole and tobramycin.
Topics: Anti-Bacterial Agents; Cefamandole; Cephalosporins; Drug Therapy, Combination; Humans; Methicillin; Penicillin Resistance; Sepsis; Staphylococcal Infections; Staphylococcus; Tobramycin; Vancomycin | 1983 |
A prospective, randomized, double blind study of preventive cefamandole therapy in patients at high risk for undergoing cholecystectomy.
Topics: Adolescent; Adult; Aged; Bile; Cefamandole; Cephalosporins; Cephalothin; Cholecystectomy; Double-Blind Method; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Premedication; Prospective Studies; Random Allocation; Risk; Sepsis; Surgical Wound Infection | 1981 |
Staphylococcal bacteremia in cancer patients: intravenous and oral antimicrobial therapy.
Topics: Administration, Oral; Cefazolin; Cephalexin; Cephalosporins; Cephalothin; Clinical Trials as Topic; Dicloxacillin; Humans; Injections, Intravenous; Microbial Sensitivity Tests; Nafcillin; Neoplasms; Sepsis; Staphylococcal Infections | 1982 |
A non-comparative, multicentre study of cefepime in the treatment of serious bacterial infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteria; Bacterial Infections; Cefepime; Cephalosporins; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Respiratory Tract Infections; Risk Factors; Sepsis; Skin Diseases, Infectious; Urinary Tract Infections | 1993 |
Once-daily versus twice-daily administration of ceftazidime in the preterm infant.
Topics: Ceftazidime; Cephalosporins; Glomerular Filtration Rate; Half-Life; Humans; Infant, Newborn; Infant, Premature; Injections, Intravenous; Prospective Studies; Sepsis | 1995 |
A prospective randomized trial of ceftazidime versus netilmicin plus mezlocillin in the empirical therapy of presumed sepsis in cirrhotic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Gentamicins; Humans; Kidney; Liver Cirrhosis; Male; Mezlocillin; Middle Aged; Netilmicin; Penicillins; Prospective Studies; Sepsis | 1997 |
Antibiotic prophylaxis for ERCP: a comparison of oral ciprofloxacin with intravenous cephazolin in the prophylaxis of high-risk patients.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bile; Cefazolin; Cephalosporins; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Ciprofloxacin; Diarrhea; Escherichia coli; Escherichia coli Infections; Female; Humans; Injections, Intravenous; Male; Microbial Sensitivity Tests; Risk Factors; Sepsis; Streptococcal Infections; Streptococcus; Treatment Outcome; Urticaria | 1998 |
Meropenem compared with ceftazidime in the empiric treatment of acute severe infections in hospitalized children. Italian Pediatric Meropenem Study Group.
Topics: Adolescent; Bacterial Infections; Ceftazidime; Cephalosporins; Child; Child, Preschool; Drug Monitoring; Hospitalization; Humans; Infant; Infant, Newborn; Liver; Meropenem; Respiratory Tract Infections; Sepsis; Skin Diseases, Infectious; Thienamycins; Treatment Outcome; Urinary Tract Infections | 1998 |
Cefpirome versus ceftazidime as empirical sepsis treatment. The Study Group.
Topics: Adult; Cefpirome; Ceftazidime; Cephalosporins; Chi-Square Distribution; Female; Humans; Infusions, Intravenous; Male; Prognosis; Sepsis; Severity of Illness Index; Treatment Outcome | 1998 |
Randomized comparative trial of cefpirome versus ceftazidime in the empirical treatment of suspected bacteraemia or sepsis. Multicentre Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; APACHE; Bacteremia; Cefpirome; Ceftazidime; Cephalosporins; Female; Humans; Male; Middle Aged; Sepsis | 1998 |
[Clinical evaluation of cefozopran for infections associated with hematological malignancies].
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anemia, Aplastic; Bacterial Infections; Bronchitis; Cefozopran; Cephalosporins; Female; Granulocytes; Hodgkin Disease; Humans; Leukemia; Leukemia, Myeloid, Acute; Leukemia, T-Cell; Leukocyte Count; Lymphoma; Male; Middle Aged; Multiple Myeloma; Peritonitis; Pneumonia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sepsis; Severity of Illness Index | 1998 |
[Clinical effects of combination therapy with cefozopran and tobramycin for severe infections in patients with hematologic diseases].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefozopran; Cephalosporins; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Infections; Male; Middle Aged; Sepsis; Tobramycin | 1999 |
A single dose of ceftriaxone administered 30 minutes before percutaneous endoscopic gastrostomy significantly reduces local and systemic infective complications.
Topics: Aged; Antibiotic Prophylaxis; Bacteremia; Ceftriaxone; Cephalosporins; Drug Costs; Economics, Pharmaceutical; Enteral Nutrition; Erythema; Exudates and Transudates; Female; Follow-Up Studies; Gastroscopy; Gastrostomy; Humans; Male; Neoplasms; Nervous System Diseases; Pneumonia; Prospective Studies; Sepsis; Suppuration; Surgical Wound Infection | 1999 |
[The efficacy of cefepime (Maxipime) in the treatment of abdominal sepsis in surgical patients].
Topics: Abdomen; Aged; Anti-Infective Agents; APACHE; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Humans; Male; Metronidazole; Middle Aged; Peritonitis; Prospective Studies; Sepsis; Surgical Wound Infection; Time Factors | 1999 |
[Efficacy and safety of cefozopran (CZOP) monotherapy and combination therapy with CZOP and amikacin (AMK) for infections accompanying hematological diseases].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefozopran; Cephalosporins; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Middle Aged; Pneumonia, Bacterial; Sepsis | 2000 |
The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients.
Topics: Adolescent; Adult; Aged; Ceftriaxone; Cephalosporins; Critical Illness; Female; Half-Life; Humans; Kidney; Male; Middle Aged; Pneumonia; Renal Insufficiency; Sepsis | 2001 |
Evaluation of endotoxin release and cytokine production induced by antibiotics in patients with Gram-negative nosocomial pneumonia.
Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Cross Infection; Cytokines; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Interleukin-1; Interleukin-6; Lipopolysaccharides; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Sepsis; Statistics, Nonparametric; Thienamycins; Tumor Necrosis Factor-alpha | 2002 |
Results of a clinical trial of cefoxitin, a new cephamycin antibiotic.
Topics: Adult; Bacterial Infections; Cefoxitin; Cephalosporins; Cephalothin; Clinical Trials as Topic; Drug Resistance, Microbial; Endocarditis, Bacterial; Humans; Osteomyelitis; Sepsis | 1977 |
Clinical experience with cefoxitin sodium.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefoxitin; Cephalosporins; Child; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Respiratory Tract Infections; Sepsis; Urinary Tract Infections | 1978 |
Clinical experience with cefoxitin sodium.
Topics: Arthritis; Bacterial Infections; Cefoxitin; Cephalosporins; Clinical Trials as Topic; Empyema, Tuberculous; Endocarditis, Bacterial; Humans; Lung Abscess; Osteomyelitis; Pneumonia; Sepsis; Urinary Tract Infections | 1978 |
An overview of results of world-wide clinical trials with cefadroxil.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Bone Diseases; Cephalosporins; Child; Child, Preschool; Clinical Trials as Topic; Female; Gastrointestinal Diseases; Genital Diseases, Female; Genital Diseases, Male; Humans; Infant; Infant, Newborn; Male; Middle Aged; Respiratory Tract Infections; Sepsis; Skin Diseases, Infectious; Urinary Tract Infections | 1978 |
Intravenous use of cephradine and cefazolin against serious infections.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefazolin; Cephalosporins; Cephradine; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Injections, Intravenous; Male; Middle Aged; Pneumonia, Pneumococcal; Sepsis; Skin Diseases, Infectious; Urinary Tract Infections | 1979 |
Management of septicemia and early death in acute leukemia.
Topics: Acute Disease; Blood Transfusion; Cephalosporins; Female; Granulocytes; Humans; Intestines; Leukemia; Leukocyte Count; Male; Patient Isolation; Penicillins; Remission, Spontaneous; Sepsis; Streptomycin | 1977 |
[Therapeutic effects of cefclidin against severe infections in patients with hematopoietic disorders. Hanshin Infection Study Group].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cephalosporins; Child; Female; Humans; Immunocompromised Host; Leukemia; Leukocyte Count; Lymphoma; Male; Middle Aged; Neutrophils; Respiratory Tract Infections; Sepsis | 1992 |
Neonatal sepsis in Turkey: the comparison between penicillin plus aminoglycoside and ampicillin plus third-generation cephalosporin chemotherapies.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Cephalosporins; Humans; Infant, Newborn; Penicillins; Sepsis; Staphylococcal Infections; Turkey | 1990 |
Comparison of cefotetan versus combination therapy in peritonitis and serious intra-abdominal sepsis.
Topics: Aged; Cefotetan; Cephalosporins; Cephradine; Clinical Trials as Topic; Drug Therapy, Combination; Gentamicins; Humans; Metronidazole; Middle Aged; Penicillin G; Peritonitis; Prospective Studies; Random Allocation; Sepsis | 1987 |
A comparison of cefuroxime and cefotetan in the prevention of wound sepsis after gastrointestinal surgery.
Topics: Bacteria; Cefotetan; Cefuroxime; Cephalosporins; Clinical Trials as Topic; Gastrointestinal Diseases; Humans; Sepsis; Surgical Wound Infection | 1987 |
Management of intra-abdominal sepsis.
Topics: Abdomen, Acute; Abdominal Injuries; Abscess; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Clinical Trials as Topic; Drainage; Drug Therapy, Combination; Humans; Peritonitis; Risk; Sepsis; Wounds, Penetrating | 1986 |
Clinical trial with cephapirin.
Topics: Adult; Bacterial Infections; Cephalosporins; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Enzymes; Female; Gonorrhea; Humans; Injections, Intramuscular; Injections, Intravenous; Male; Middle Aged; Peritonitis; Respiratory Tract Infections; Sepsis; Urinary Tract Infections | 1972 |
Laboratory and clinical studies on cefazolin, a new derivative of semisynthetic cephalosporin.
Topics: Adult; Cephalosporins; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Tolerance; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Intestinal Absorption; Microbial Sensitivity Tests; Pain; Peritonitis; Sepsis; Urinary Tract Infections | 1972 |
[Results of clinical trials with cephadrine in children].
Topics: Adolescent; Bacterial Infections; Cephalosporins; Child; Child, Preschool; Clinical Trials as Topic; Cyclohexanes; Diarrhea; Drug Evaluation; Enterobacteriaceae Infections; Escherichia coli Infections; Haemophilus Infections; Hematoma; Humans; Infant; Klebsiella Infections; Leukocytosis; Nausea; Osteomyelitis; Otitis; Pharyngitis; Pneumococcal Infections; Pneumonia; Proteus Infections; Pyelonephritis; Pyoderma; Sepsis; Sinusitis; Staphylococcal Infections; Streptococcal Infections; Time Factors; Vomiting | 1973 |
Antibacterial prophylaxis in prostatectomy patients.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Bacteriuria; Cephalosporins; Clinical Trials as Topic; Fever; Gentamicins; Humans; Kanamycin; Male; Middle Aged; Nitrofurantoin; Postoperative Complications; Prognosis; Prostatectomy; Sepsis; Sulfisoxazole; Tetracycline; Urinary Tract Infections | 1974 |
Phlebitis associated with cephalosporins: cephapirin versus cephalothin.
Topics: Acetamides; Anti-Infective Agents; Cellulitis; Cephalosporins; Cephalothin; Clinical Trials as Topic; Erythema; Gentamicins; Humans; Injections, Intravenous; Phlebitis; Pneumonia; Pyridines; Sepsis; Sulfides; Urinary Tract Infections | 1973 |
285 other study(ies) available for cephalosporin c and Blood Poisoning
Article | Year |
---|---|
CLINICAL TRIAL OF CEPHALORIDINE (CEPORIN), A NEW BROAD-SPECTRUM ANTIBIOTIC DERIVED FROM CEPHALOSPORIN C.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; Blood Chemical Analysis; Cephaloridine; Cephalosporins; Drug Resistance; Drug Resistance, Microbial; Humans; Infections; Meningitis; Penicillins; Pyelonephritis; Research; Sepsis; Statistics as Topic; Urine | 1964 |
Cefiderocol- Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Cefiderocol; Cephalosporins; Colistin; Humans; Pneumonia, Ventilator-Associated; Retrospective Studies; Sepsis | 2022 |
The hospital environment versus carriage: transmission pathways for third-generation cephalosporin-resistant bacteria in blood in neonates in a low-resource country healthcare setting.
Topics: Anti-Bacterial Agents; Bacteremia; Bacteria; Cephalosporins; Delivery of Health Care; Escherichia coli; Hospitals; Humans; Infant; Infant, Newborn; Klebsiella pneumoniae; Sepsis; Tanzania | 2022 |
Emergence of a Novel NDM-5-Producing Sequence Type 4523 Klebsiella pneumoniae Strain Causing Bloodstream Infection in China.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cephalosporins; Colistin; Female; Formaldehyde; Humans; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Plasmids; Sepsis | 2022 |
[A 10-year retrospective study of pathogens and antimicrobial resistance in neonatal sepsis].
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Humans; Infant; Infant, Newborn; Infant, Premature; Microbial Sensitivity Tests; Neonatal Sepsis; Penicillins; Retrospective Studies; Sepsis | 2022 |
Effect of resistance to third-generation cephalosporins on morbidity and mortality from bloodstream infections in Blantyre, Malawi: a prospective cohort study.
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Escherichia coli; Humans; Malawi; Morbidity; Prospective Studies; Sepsis | 2022 |
ESBL encoding third-generation cephalosporin resistance observed in bloodstream infection in India.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Communicable Diseases; Escherichia coli Infections; Humans; India; Microbial Sensitivity Tests; Sepsis | 2023 |
Clinical and bacteriological profile of culture-negative and culture-proven neonatal sepsis in Palembang, Indonesia.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Humans; Indonesia; Infant, Newborn; Neonatal Sepsis; Sepsis | 2022 |
CEFTO-CURE study: CEFTObiprole Clinical Use in Real-lifE - a multi-centre experience in Italy.
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Humans; Italy; Male; Middle Aged; Pneumonia; Retrospective Studies; Sepsis | 2023 |
Compassionate use of a novel β-lactam enhancer-based investigational antibiotic cefepime/zidebactam (WCK 5222) for the treatment of extensively-drug-resistant NDM-expressing Pseudomonas aeruginosa infection in an intra-abdominal infection-induced sepsis p
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Compassionate Use Trials; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Monobactams; Polymyxins; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis | 2023 |
Should cefepime be used for any bloodstream infections caused by ceftriaxone-resistant, cefepime-susceptible Enterobacterales?
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefepime; Ceftriaxone; Cephalosporins; Humans; Microbial Sensitivity Tests; Sepsis | 2023 |
Mortality associated with third-generation cephalosporin resistance in Enterobacterales bloodstream infections at eight sub-Saharan African hospitals (MBIRA): a prospective cohort study.
Topics: Anti-Bacterial Agents; Cephalosporin Resistance; Cephalosporins; Cohort Studies; Escherichia coli; Hospital Mortality; Hospitals; Humans; Infant, Newborn; Prospective Studies; Sepsis | 2023 |
Extreme resistance to the novel siderophore-cephalosporin cefiderocol in an extensively drug-resistant Klebsiella pneumoniae strain causing fatal pneumonia with sepsis: genomic analysis and synergistic combinations for resistance reversal.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefiderocol; Cephalosporins; Drug Resistance, Multiple, Bacterial; Genomics; Humans; Klebsiella pneumoniae; Sepsis; Siderophores | 2023 |
Antimicrobial activity of ceftolozane/tazobactam tested against contemporary (2015-2017) Pseudomonas aeruginosa isolates from a global surveillance programme.
Topics: Asia; Cephalosporins; Europe; Female; Global Health; Humans; Latin America; Male; Microbial Sensitivity Tests; North America; Pacific Islands; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Public Health Surveillance; Sepsis; Skin Diseases, Bacterial; Tazobactam | 2020 |
Combined Molecular and Phenotypic Antimicrobial Susceptibility Testing Is Beneficial in Detection of ESBL and AmpC Beta-Lactamase Producing Isolates of Enterobacteriaceae in Pediatric Patients with Bloodstream Infections.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Cephalosporins; Child; Enterobacteriaceae; Genotype; Humans; Microbial Sensitivity Tests; Phenotype; Sepsis | 2020 |
Screening for Third-Generation Cephalosporin-Resistant Bacteria Reduces the Incidence on Late-Onset Sepsis and Antibiotic use in Neonates.
Topics: Anti-Bacterial Agents; Bacteria; Cephalosporins; Drug Resistance, Bacterial; Humans; Incidence; Infant, Newborn; Retrospective Studies; Sepsis | 2020 |
An International Prospective Cohort Study To Validate 2 Prediction Rules for Infections Caused by Third-generation Cephalosporin-resistant Enterobacterales.
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cross Infection; Humans; Prospective Studies; Sepsis | 2021 |
Frequency and antimicrobial susceptibility of bacteria causing bloodstream infections in pediatric patients from United States (US) medical centers (2014-2018): therapeutic options for multidrug-resistant bacteria.
Topics: Adolescent; Anti-Infective Agents; Azabicyclo Compounds; Bacteria; Bacterial Proteins; beta-Lactamases; Candida; Ceftaroline; Ceftazidime; Cephalosporins; Child; Child, Preschool; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Infant; Microbial Sensitivity Tests; Oxacillin; Sepsis; United States | 2020 |
Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses of Cefiderocol, a Parenteral Siderophore Cephalosporin, in Patients with Pneumonia, Bloodstream Infection/Sepsis, or Complicated Urinary Tract Infection.
Topics: Anti-Bacterial Agents; Bacteremia; Cefiderocol; Cephalosporins; Humans; Microbial Sensitivity Tests; Pneumonia; Sepsis; Siderophores; Urinary Tract Infections | 2021 |
The need for gentamicin adjunctive to cefuroxime as empirical sepsis therapy: a local protocol evaluation.
Topics: Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Gentamicins; Humans; Sepsis | 2021 |
Antimicrobial activities of LCB10-0200, a novel siderophore cephalosporin, against the clinical isolates of Pseudomonas aeruginosa and other pathogens.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Disease Models, Animal; Female; Humans; Male; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Sepsis; Siderophores; Skin Diseases, Bacterial; Treatment Outcome; Urinary Tract Infections | 2017 |
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Febrile Neutropenia; Humans; Iatrogenic Disease; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Tazobactam; Thienamycins; Tobramycin | 2017 |
Efficacy of Ceftriaxone, Cefepime, Doxycycline, Ciprofloxacin, and Combination Therapy for Vibrio vulnificus Foodborne Septicemia.
Topics: Animals; Anti-Bacterial Agents; Cefepime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Doxycycline; Drug Synergism; Drug Therapy, Combination; Female; Foodborne Diseases; Humans; Mice; Seafood; Sepsis; Vibrio Infections; Vibrio vulnificus | 2017 |
Adding Azithromycin to Cephalosporin for Cesarean Delivery Infection Prophylaxis: A Cost-Effectiveness Analysis.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Cephalosporins; Cesarean Section; Cost-Benefit Analysis; Endometritis; Female; Humans; Maternal Mortality; Models, Economic; Postoperative Complications; Pregnancy; Sepsis; Surgical Wound Infection | 2017 |
[Urosepsis].
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporins; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Sepsis; Urinary Tract Infections | 2018 |
[Urosepsis].
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporins; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Sepsis; Urinary Tract Infections | 2018 |
Alarming levels of antimicrobial resistance among sepsis patients admitted to ICU in a tertiary care hospital in India - a case control retrospective study.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; beta-Lactamases; Case-Control Studies; Cephalosporins; Cross Infection; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enterobacteriaceae; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Feces; Genetic Variation; HeLa Cells; Hospitalization; Humans; India; Intensive Care Units; Polymerase Chain Reaction; Prevalence; Retrospective Studies; Sepsis; Tertiary Care Centers | 2018 |
Using local clinical and microbiological data to develop an institution specific carbapenem-sparing strategy in sepsis: a nested case-control study.
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Cephalosporins; Cohort Studies; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Sepsis | 2019 |
Adequacy of empiric gram-negative coverage for septic patients at an academic medical center.
Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Female; Gram-Negative Bacteria; Humans; Levofloxacin; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Shock, Septic; Virginia; Young Adult | 2019 |
Outcomes of Third-Generation Cephalosporin Plus Ciprofloxacin or Doxycycline Therapy in Patients with Vibrio vulnificus Septicemia: A Propensity Score-Matched Analysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Cephalosporins; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Republic of Korea; Retrospective Studies; Sepsis; Treatment Outcome; Vibrio Infections; Vibrio vulnificus; Young Adult | 2019 |
Management of cellulitis and the role of the nurse: a 5-year retrospective multicentre study in Fako, Cameroon.
Topics: Abscess; Adolescent; Adult; Alcohol Drinking; Aminoglycosides; Anti-Bacterial Agents; Cameroon; Cellulitis; Cephalosporins; Debridement; Disease Management; Drainage; Female; HIV Infections; Humans; Male; Middle Aged; Necrosis; Nitroimidazoles; Nurse's Role; Nurses; Penicillins; Postoperative Complications; Retrospective Studies; Risk Factors; Sepsis; Smoking; Ulcer; Wounds and Injuries | 2019 |
Fatal case of toxic epidermal necrolysis caused by cefozopran and associated with psoriasis.
Topics: Aged; Anti-Bacterial Agents; Cefozopran; Cephalosporins; Disseminated Intravascular Coagulation; Fatal Outcome; Female; Humans; Psoriasis; Pyelonephritis; Sepsis; Shock, Septic; Skin; Stevens-Johnson Syndrome; Ultraviolet Therapy | 2014 |
Characterization of CTX-M-14 and CTX-M-15 producing Escherichia coli strains causing neonatal sepsis.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Clone Cells; Escherichia coli; Escherichia coli Infections; Female; Gene Expression; Gentamicins; Humans; Infant, Newborn; Microbial Sensitivity Tests; Plasmids; Sepsis | 2014 |
Predictive value of prior colonization and antibiotic use for third-generation cephalosporin-resistant enterobacteriaceae bacteremia in patients with sepsis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Cephalosporins; Drug Utilization; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiologic Methods; Female; Guideline Adherence; Humans; Male; Middle Aged; Netherlands; Predictive Value of Tests; Retrospective Studies; Sepsis; Young Adult | 2015 |
Activity of ceftaroline and comparator agents tested against Staphylococcus aureus from patients with bloodstream infections in US medical centres (2009-13).
Topics: Academic Medical Centers; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Humans; Microbial Sensitivity Tests; Sepsis; Staphylococcal Infections; Staphylococcus aureus; United States | 2015 |
Sepsis caused by Listeria monocytogenes during chemotherapy for small cell carcinoma of the thymus.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Antineoplastic Agents; Carboplatin; Carcinoma, Small Cell; Cefepime; Cephalosporins; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Listeria monocytogenes; Listeriosis; Meropenem; Neoplasm Recurrence, Local; Sepsis; Thienamycins; Thymus Gland; Thymus Neoplasms; Treatment Outcome | 2015 |
Pediatric invasive disease due to Haemophilus influenzae serogroup A in Riyadh, Saudi Arabia: case series.
Topics: Anti-Bacterial Agents; Bacterial Capsules; Bacteriological Techniques; Cephalosporins; Cerebrospinal Fluid; Haemophilus influenzae; Haemophilus Vaccines; Humans; Infant; Male; Meningitis, Haemophilus; Saudi Arabia; Sepsis; Serogroup; Treatment Outcome; Vancomycin | 2016 |
Efficacy of ceftaroline versus vancomycin in an experimental foreign-body and systemic infection model caused by biofilm-producing methicillin-resistant Staphylococcus epidermidis.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Biofilms; Ceftaroline; Cephalosporins; Disease Models, Animal; Female; Foreign Bodies; Methicillin Resistance; Mice, Inbred C57BL; Microbial Sensitivity Tests; Random Allocation; Sepsis; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Vancomycin | 2016 |
[METROPLASTY FOR OBSTETRIC PERITONITIS, ARISING IN THE BACKGROUND SUTURE FAILURE OF THE UTERUS].
Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Cesarean Section; Female; Humans; Hysterotomy; Organ Sparing Treatments; Ozone; Peritonitis; Sepsis; Surgical Wound Infection; Systemic Inflammatory Response Syndrome; Uterus; Young Adult | 2016 |
Epididymal abscess in renal transplant: uncommon presentation of Klebsiella septicemia.
Topics: Abscess; Adult; Cephalosporins; Cyclosporine; Epididymis; Genital Diseases, Male; Humans; Immunosuppressive Agents; Kidney Transplantation; Klebsiella Infections; Klebsiella pneumoniae; Male; Mycophenolic Acid; Prednisolone; Sepsis | 2010 |
Treatment of septicaemia and severe bacterial infections in foals with a new cefquinome formulation: a field study.
Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Cephalosporins; Horse Diseases; Horses; Immunoglobulin G; Injections, Intramuscular; Injections, Intravenous; Random Allocation; Sepsis; Treatment Outcome | 2009 |
[Meningococcal infections].
Topics: Cephalosporins; Child; Child, Preschool; Early Diagnosis; Germany; Humans; Infant; Meningitis, Meningococcal; Meningococcal Infections; Meningococcal Vaccines; Penicillin G; Sepsis | 2010 |
Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis.
Topics: Acinetobacter Infections; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Cohort Studies; Drug Therapy, Combination; Escherichia coli Infections; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Sepsis; Shock, Septic | 2010 |
Early-onset septicemia due to CMY-2-producing Escherichia coli in a woman with blunt abdominal trauma.
Topics: Abdominal Injuries; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Sepsis; Taiwan | 2009 |
Characterization of CSP-1, a novel extended-spectrum beta-lactamase produced by a clinical isolate of Capnocytophaga sputigena.
Topics: Amino Acid Sequence; Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Capnocytophaga; Cephalosporins; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sepsis | 2010 |
Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Chromatography, High Pressure Liquid; Drug Therapy, Combination; Female; Humans; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Prospective Studies; Sepsis; Shock, Septic; Tazobactam; Thienamycins | 2010 |
Enhanced in vivo activity of cefditoren in pre-immunized mice against penicillin-resistant S. pneumoniae (serotypes 6B, 19F and 23F) in a sepsis model.
Topics: Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Antibody Specificity; Cephalosporins; Disease Models, Animal; Female; HL-60 Cells; Humans; Immunization; Immunization, Passive; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Penicillin Resistance; Phagocytes; Phagocytosis; Sepsis; Serotyping; Streptococcus pneumoniae; Vaccines, Inactivated | 2010 |
[Actual aspects of sepsis].
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitals; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Retrospective Studies; Russia; Sepsis; Vancomycin | 2011 |
Cefepime-associated thrombocytopenia in a critically ill patient.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cefepime; Cephalosporins; Critical Illness; Cross Infection; Humans; Intensive Care Units; Male; Middle Aged; Pneumothorax; Rhabdomyolysis; Sepsis; Thrombocytopenia | 2011 |
Prospective study of antibiotic prophylaxis for prostate biopsy involving >1100 men.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy; Cephalosporins; Drug Resistance, Bacterial; Drug Resistance, Multiple; Fever; Humans; Male; Meropenem; Middle Aged; Ofloxacin; Prospective Studies; Prostate; Prostatic Neoplasms; Quinolones; Sepsis; Thienamycins; Treatment Outcome | 2012 |
Cutaneous abscess leading to sepsis by Aeromonas hydrophila.
Topics: Abscess; Aeromonas hydrophila; Cefepime; Cephalosporins; Ciprofloxacin; Fever; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Sepsis; Skin Diseases, Bacterial; Young Adult | 2013 |
Cefovecin (Convenia) for the treatment of septic peritonitis in a female lion (Panthera leo).
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Cephalosporins; Female; Hysterectomy; Lions; Meloxicam; Pain; Peritonitis; Pyometra; Sepsis; Thiazines; Thiazoles | 2012 |
Case-control study of drug monitoring of β-lactams in obese critically ill patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Case-Control Studies; Cefepime; Ceftazidime; Cephalosporins; Drug Monitoring; Enzyme Inhibitors; Female; Humans; Male; Meropenem; Middle Aged; Obesity; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Renal Replacement Therapy; Sepsis; Shock, Septic; Tazobactam; Thienamycins; Young Adult | 2013 |
Plasma and tissue pharmacokinetics of cefpirome in patients with sepsis.
Topics: Aged; Aged, 80 and over; Cefpirome; Cephalosporins; Female; Humans; Male; Middle Aged; Prospective Studies; Sepsis; Tissue Distribution | 2002 |
Protein synthesis inhibiting clindamycin improves outcome in a mouse model of Staphylococcus aureus sepsis compared with the cell wall active ceftriaxone.
Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Cell Wall; Cephalosporins; Clindamycin; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Protein Synthesis Inhibitors; Sepsis; Staphylococcal Infections; Treatment Outcome | 2002 |
Clinical and bacteriological results from the administration of Cefepime (Maxipime) in patients with severe sepsis.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteria; Cefepime; Cephalosporins; Female; Humans; Male; Middle Aged; Sepsis; Treatment Outcome | 2002 |
Prognostic factors for 246 neonates with infections.
Topics: Anti-Bacterial Agents; Birth Weight; Cephalosporins; Gestational Age; Humans; Immunocompromised Host; Infant, Newborn; Penicillins; Prognosis; Risk Factors; Sepsis | 2003 |
Protection with antibody to tumor necrosis factor differs with similarly lethal Escherichia coli versus Staphylococcus aureus pneumonia in rats.
Topics: Administration, Inhalation; Animals; Antibodies; Bronchoalveolar Lavage Fluid; Cefotiam; Cephalosporins; Escherichia coli; Escherichia coli Infections; Injections, Intraperitoneal; Interleukin-6; Intubation, Intratracheal; Leukocyte Count; Lymphocyte Count; Male; Neutrophils; Oxygen; Oxygen Consumption; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Rats; Rats, Wistar; Sepsis; Staphylococcus aureus; Survival Analysis; Tumor Necrosis Factor-alpha | 2003 |
Incidence, treatment and outcome of peripartum sepsis.
Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Cesarean Section; Female; Humans; Incidence; Infant, Newborn; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Puerperal Infection; Retrospective Studies; Risk Factors; Sepsis | 2003 |
[Morganella morganii and early-onset neonatal infection].
Topics: Administration, Oral; Adult; Aminoglycosides; Amoxicillin; Antibiotic Prophylaxis; Cephalosporins; Chorioamnionitis; Enterobacteriaceae Infections; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Infant, Newborn, Diseases; Morganella morganii; Penicillins; Pregnancy; Sepsis | 2004 |
Pharmacodynamics of S-3578, a novel cephem, in murine lung and systemic infection models.
Topics: Animals; Area Under Curve; Cefepime; Cephalosporins; Colony Count, Microbial; Female; Injections, Subcutaneous; Lung; Methicillin Resistance; Mice; Mice, Inbred CBA; Mice, Inbred ICR; Microbial Sensitivity Tests; Pneumonia, Pneumococcal; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Survival Analysis; Tissue Distribution | 2004 |
Antibiotic-mediated release of tumour necrosis factor alpha and norharman in patients with hospital-acquired pneumonia and septic encephalopathy.
Topics: Adult; Aged; Aged, 80 and over; Brain Diseases; Carbolines; Cephalosporins; Chi-Square Distribution; Cross Infection; Female; Harmine; Humans; Intensive Care Units; Male; Middle Aged; Pneumonia; Prospective Studies; Retrospective Studies; Sepsis; Statistics, Nonparametric; Tumor Necrosis Factor-alpha | 2004 |
Monotherapy versus dual therapy based on risk categorization of febrile neutropenic patients.
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Therapy, Combination; Fever; Hematologic Diseases; Humans; Immunocompromised Host; Neutropenia; Opportunistic Infections; Risk Assessment; Sepsis | 2004 |
n-6 polyunsaturated fatty acids enhance the activities of ceftazidime and amikacin in experimental sepsis caused by multidrug-resistant Pseudomonas aeruginosa.
Topics: alpha-Linolenic Acid; Amikacin; Animals; Anti-Bacterial Agents; Arachidonic Acid; Ceftazidime; Cephalosporins; Colony Count, Microbial; Drug Resistance, Multiple, Bacterial; Drug Synergism; Fatty Acids, Unsaturated; Lipopolysaccharides; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Sepsis; Tumor Necrosis Factor-alpha | 2004 |
Pharmacokinetics and pharmacodynamics of cefpirome in subcutaneous adipose tissue of septic patients.
Topics: Adipose Tissue; Adult; Area Under Curve; Cefpirome; Cephalosporins; Chromatography, Micellar Electrokinetic Capillary; Colony Count, Microbial; Female; Humans; Male; Microbial Sensitivity Tests; Microdialysis; Pseudomonas aeruginosa; Sepsis; Staphylococcus aureus | 2005 |
Effects of hyperbaric oxygen treatment on liver functions, oxidative status and histology in septic rats.
Topics: Animals; Cefepime; Cephalosporins; Hyperbaric Oxygenation; Liver; Male; Oxidative Stress; Rats; Rats, Wistar; Sepsis; Thiobarbituric Acid Reactive Substances | 2005 |
Combined cephalosporin aminoglycoside therapy in gram-negative sepsis. The choice of cephalosporin.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteria, Anaerobic; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Sepsis | 1989 |
Severe metabolic acidemia, hypoglycemia, and sepsis in a 3-week-old quarter horse foal.
Topics: Acidosis; Ampicillin; Animals; Anti-Bacterial Agents; Atropine; Blood Cell Count; Blood Chemical Analysis; Cephalosporins; Electrolytes; Female; Fluid Therapy; Gentamicins; Glucose; Horse Diseases; Horses; Hydrogen-Ion Concentration; Hypoglycemia; Infusions, Intravenous; Sepsis; Shock; Sodium Bicarbonate; Uveitis | 2006 |
[Maxipime in the treatment of neonatal sepsis].
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Humans; Infant, Newborn; Sepsis; Treatment Outcome | 2006 |
Use of cefepime for the treatment of infections caused by extended spectrum: beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Hospitals, Urban; Humans; India; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Thienamycins | 2007 |
Effect of severity disease on the pharmacokinetics of cefuroxime in children with multiple organ system failure.
Topics: Adolescent; Alanine Transaminase; Algorithms; Area Under Curve; Aspartate Aminotransferases; Cefuroxime; Cephalosporins; Child; Child, Preschool; Chromatography, High Pressure Liquid; Creatinine; Female; Half-Life; Humans; Infant; Liver Function Tests; Male; Multiple Organ Failure; Sepsis; Urea | 2008 |
[Clinical and microbiologic research with cephaloridine].
Topics: Abscess; Adult; Bronchopneumonia; Cephaloridine; Cephalosporins; Child; Child, Preschool; Empyema; Female; Humans; Infant; Kidney Diseases; Male; Meningitis; Pleurisy; Sepsis; Staphylococcal Infections; Staphylococcus | 1967 |
Cephaloridine and penicillin G in the treatment of pneumococcal pneumonia. A comparative study.
Topics: Adult; Aged; Blood Urea Nitrogen; Cephalosporins; Female; Humans; Male; Middle Aged; Penicillin G; Pneumococcal Infections; Pneumonia, Pneumococcal; Sepsis; Uremia | 1967 |
Quaternary heterocyclylamino beta-lactams. IV. Comparison of the in vivo antibacterial activities of L-640,876, mecillinam, cefoxitin and cefotaxime.
Topics: Amdinocillin; Animals; Anti-Bacterial Agents; Cefotaxime; Cefoxitin; Cephalosporins; Gram-Negative Bacteria; Kinetics; Mice; Microbial Sensitivity Tests; Penicillanic Acid; Sepsis; Tissue Distribution | 1983 |
Cefodizime, an aminothiazolyl cephalosporin. III. Therapeutic activity against experimentally induced pneumonia in mice.
Topics: Animals; Cefotaxime; Cephalosporins; Mice; Pneumonia; Sepsis | 1984 |
Ceftazidime--a new extended-spectrum cephalosporin.
Topics: Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Ceftazidime; Cephalosporins; Drug Evaluation; Drug Resistance, Microbial; Female; Half-Life; Humans; Male; Middle Aged; Respiratory Tract Infections; Sepsis; Urinary Tract Infections; Wound Infection | 1982 |
Ceftazidime and salmonella.
Topics: Adult; Ceftazidime; Cephalosporins; Humans; Male; Salmonella Infections; Salmonella typhimurium; Sepsis | 1982 |
[Use of moxalactam in intensive care units: clinical and bacteriological results related to serum and bronchial concentrations ].
Topics: Adult; Aged; Cephalosporins; Cephamycins; Critical Care; Cross Infection; Female; Humans; Male; Middle Aged; Moxalactam; Respiratory Tract Infections; Sepsis; Sputum | 1982 |
Clinical evaluation of moxalactam therapy.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Sepsis | 1982 |
[Levels of moxalactam in the cerebral ventricles during the treatment of Klebsiella septicemia].
Topics: Cephalosporins; Cephamycins; Cerebral Ventricles; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Moxalactam; Sepsis | 1983 |
Clinical evaluation of moxalactam: evidence of decreased efficacy in gram-positive aerobic infections.
Topics: Adolescent; Adult; Aged; Anaerobiosis; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Female; Humans; Infant; Male; Meningitis; Middle Aged; Moxalactam; Peritonitis; Pneumonia; Sepsis; Urinary Tract Infections | 1983 |
[Clinical studies on cefoperazone in children].
Topics: Cefoperazone; Cephalosporins; Child; Child, Preschool; Humans; Infant; Respiratory Tract Infections; Sepsis; Urinary Tract Infections | 1983 |
[Treatment of septicemia with latamoxef. Multicentric study of 60 cases].
Topics: Adolescent; Adult; Aged; Blood Bactericidal Activity; Cephalosporins; Cephamycins; Female; Follow-Up Studies; Humans; Male; Middle Aged; Moxalactam; Sepsis | 1982 |
Clinical evaluation of ceftazidime in Japan.
Topics: Adult; Aged; Bacterial Infections; Ceftazidime; Cephalosporins; Drug Eruptions; Female; Genital Diseases, Female; Humans; Japan; Male; Middle Aged; Nausea; Respiratory Tract Infections; Sepsis; Surgical Wound Infection; Urinary Tract Infections; Vomiting | 1983 |
Ceftazidime treatment in intensive care patients.
Topics: Abscess; Adolescent; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Ceftazidime; Cephalosporins; Drug Eruptions; Drug Resistance, Microbial; Female; Humans; Intensive Care Units; Male; Middle Aged; Pseudomonas Infections; Respiratory Tract Infections; Sepsis; Urinary Tract Infections | 1983 |
Ceftazidime in septicaemia.
Topics: Adult; Aged; Ceftazidime; Cephalosporins; Coombs Test; Drug Eruptions; Escherichia coli Infections; Female; Fever; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Sepsis | 1983 |
[Cephotaxim treatment in gynecology and obstetrics. Clinical experiences].
Topics: Abscess; Adolescent; Adult; Cefotaxime; Cephalosporins; Endometritis; Female; Humans; Middle Aged; Pelvic Inflammatory Disease; Sepsis | 1980 |
Cefotaxime in the treatment of septicaemia and endocarditis.
Topics: Adolescent; Adult; Aged; Cefotaxime; Cephalosporins; Endocarditis, Bacterial; Female; Humans; Male; Middle Aged; Sepsis | 1980 |
Management of severe systemic infections caused by multiple resistant organisms.
Topics: Bacterial Infections; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Female; Humans; Male; Meningitis; Respiratory Tract Infections; Sepsis; Urinary Tract Infections | 1980 |
Cefotaxime in septicaemia including typhoid fever.
Topics: Adult; Aged; Cefotaxime; Cephalosporins; Humans; Male; Middle Aged; Sepsis; Typhoid Fever | 1980 |
The evaluation of efficacy and safety of cefotaxime: a review of 2500 cases.
Topics: Adolescent; Adult; Age Factors; Aged; Bacterial Infections; Cefotaxime; Cephalosporins; Child; Child, Preschool; Female; Gonorrhea; Humans; Infant; Infant, Newborn; Male; Meningitis; Middle Aged; Respiratory Tract Infections; Sepsis; Sex Factors | 1980 |
[Clinical experiences with cefotaxim].
Topics: Acute Disease; Adult; Aged; Cefotaxime; Cephalosporins; Female; Humans; Male; Middle Aged; Respiratory Tract Diseases; Sepsis; Urinary Tract Infections | 1980 |
[The use of cefotaxime against infections (author's transl)].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefotaxime; Cephalosporins; Child; Female; Humans; Male; Middle Aged; Sepsis; Urinary Tract Infections | 1981 |
[Place of cefotaxime in the treatment of septicaemias due to enterobacteriaceae (author's transl)].
Topics: Adult; Aged; Cefotaxime; Cephalosporins; Enterobacteriaceae Infections; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Male; Middle Aged; Sepsis | 1981 |
[Cefotaxime in septicaemia and severe infections due to multiresistant Gram-negative bacilli (author's transl)].
Topics: Adult; Aged; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae Infections; Female; Humans; Male; Meningitis; Middle Aged; Pseudomonas Infections; Respiratory Tract Infections; Sepsis; Urinary Tract Infections | 1981 |
[Clinical experience of cefotaxime (author's transl)].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefotaxime; Cephalosporins; Female; Humans; Male; Middle Aged; Pneumonia; Sepsis; Urinary Tract Infections | 1981 |
[Treatment of Gram-negative septicaemia with cefotaxime: 16 cases (author's transl)].
Topics: Adolescent; Adult; Aged; Cefotaxime; Cephalosporins; Child; Enterobacteriaceae Infections; Humans; Middle Aged; Sepsis | 1981 |
[Cefotaxime in infections caused by multi-resistant microorganisms].
Topics: Adult; Aged; Bacterial Infections; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Female; Humans; Infant; Male; Middle Aged; Sepsis | 1981 |
Serratia endocarditis in a pediatric burn patient. Cure with cefotaxime.
Topics: Burns; Cefotaxime; Cephalosporins; Child; Drug Resistance, Microbial; Endocarditis, Bacterial; Enterobacteriaceae Infections; Female; Humans; Sepsis; Serratia marcescens; Tricuspid Valve | 1981 |
[Moxalactam in pediatrics. Clinical and pharmacokinetic experience. Apropos of 37 cases].
Topics: Adolescent; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Enterobacteriaceae Infections; Female; Humans; Infant; Infant, Newborn; Kinetics; Male; Meningitis, Haemophilus; Moxalactam; Respiratory Tract Infections; Sepsis; Urinary Tract Infections | 1983 |
A case of recurrent salmonella septicaemia in an infant.
Topics: Cefuroxime; Cephalosporins; Chloramphenicol; Drug Combinations; Female; Humans; IgA Deficiency; Infant; Recurrence; Salmonella Infections; Sepsis; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1984 |
Ceftazidime: a new approach in the treatment of moderate and severe infections.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Ceftazidime; Cephalosporins; Child; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Male; Meningitis; Middle Aged; Peritonitis; Pseudomonas Infections; Respiratory Tract Infections; Sepsis; Skin Diseases, Infectious; Urinary Tract Infections | 1983 |
The evaluation of ceftazidime in the treatment of bacterial infections in eighty seriously ill patients.
Topics: Adolescent; Adult; Aged; Anaphylaxis; Bacterial Infections; Ceftazidime; Cephalosporins; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Respiratory Tract Infections; Sepsis; Skin Diseases, Infectious; Urinary Tract Infections | 1983 |
Ceftazidime, as a single antibiotic, in the treatment of multi-resistant Gram-negative infections in intensive care.
Topics: Adult; Aged; Bacterial Infections; Ceftazidime; Cephalosporins; Child; Female; Humans; Intensive Care Units; Male; Middle Aged; Respiratory Tract Infections; Sepsis; Urinary Tract Infections | 1983 |
Ceftazidime in intensive care medicine and haemofiltration.
Topics: Bacterial Infections; Blood; Cardiovascular Diseases; Ceftazidime; Cephalosporins; Female; Humans; Intensive Care Units; Kidney Failure, Chronic; Male; Respiratory Tract Infections; Sepsis; Ultrafiltration | 1983 |
Evaluation of ceftazidime in the treatment of severe bacterial infection.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Ceftazidime; Cephalosporins; Child; Female; Humans; Male; Middle Aged; Osteomyelitis; Pneumonia; Sepsis; Urinary Tract Infections; Wound Infection | 1983 |
Open study of ceftazidime in serious infections due to multiply-resistant bacteria.
Topics: Abscess; Adolescent; Adult; Aged; Bacterial Infections; Bronchopneumonia; Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Osteomyelitis; Peritonitis; Sepsis; Urinary Tract Infections; Wound Infection | 1983 |
Ceftazidime as a single agent in the treatment of severe Pseudomonas aeruginosa infections.
Topics: Adolescent; Adult; Aged; Ceftazidime; Cephalosporins; Child; Drug Resistance, Microbial; Eosinophilia; Female; Humans; Liver Function Tests; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas Infections; Respiratory Tract Infections; Sepsis; Urinary Tract Infections | 1983 |
Ceftazidime in the therapy of serious Gram-negative bacillary infections.
Topics: Acute Kidney Injury; Adult; Aged; Anaphylaxis; Bacterial Infections; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Osteomyelitis; Pseudomonas Infections; Respiratory Tract Infections; Sepsis; Wound Infection | 1983 |
Multiple dose pharmacokinetics and therapeutic results with ceftazidime.
Topics: Adult; Aged; Bacterial Infections; Ceftazidime; Cephalosporins; Female; Humans; Kinetics; Lung Diseases, Obstructive; Male; Middle Aged; Pneumonia; Sepsis; Urinary Tract Infections | 1983 |
Ceftazidime in clinical practice - a summary.
Topics: Bacterial Infections; Ceftazidime; Cephalosporins; Coombs Test; Diarrhea; Eosinophilia; Humans; Kidney; Kinetics; Liver Function Tests; Microbial Sensitivity Tests; Respiratory Tract Infections; Sepsis; Urinary Tract Infections | 1983 |
Ceftazidime therapy of infections caused by Enterobacteriaceae and Pseudomonas aeruginosa.
Topics: Adult; Aged; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis | 1983 |
Clinical efficacy of ceftazidime. Treatment of serious infection due to multiresistant Pseudomonas and other gram-negative bacteria.
Topics: Acute Disease; Adolescent; Adult; Aged; Bacterial Infections; Ceftazidime; Cephalosporins; Child; Child, Preschool; Cystic Fibrosis; Drug Evaluation; Drug Resistance, Microbial; Female; Gram-Negative Bacteria; Humans; Infant; Lung Diseases; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Urinary Tract Infections | 1984 |
[A child case of Yersinia pseudotuberculosis septicemia].
Topics: Cephalosporins; Child, Preschool; Humans; Male; Moxalactam; Sepsis; Yersinia Infections; Yersinia pseudotuberculosis Infections | 1984 |
Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates.
Topics: Amikacin; Bacteria; Carbenicillin; Cefazolin; Cephalosporins; Cephamycins; Culture Media; Humans; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Sepsis; Species Specificity; Ticarcillin; Tobramycin | 1980 |
[Diagnosis and therapy of septic syndromes].
Topics: Azlocillin; Cephalosporins; Cephalothin; Humans; Mezlocillin; Penicillins; Sepsis; Splenomegaly | 1981 |
The role of the laboratory in the planned use of cefoperazone for the treatment of difficult Pseudomonas infections.
Topics: Adult; Aged; Aortitis; Cefoperazone; Cephalosporins; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Osteomyelitis; Pseudomonas; Pseudomonas Infections; Sepsis | 1981 |
Clinical studies with cefoperazone in the treatment of bacterial infections in surgical practice.
Topics: Abscess; Adult; Aged; Bacterial Infections; Cefoperazone; Cephalosporins; Humans; Liver Abscess; Male; Middle Aged; Postoperative Complications; Sepsis | 1981 |
Moxalactam therapy for bacterial infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Female; Humans; Infant; Klebsiella Infections; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Pseudomonas Infections; Sepsis; Structure-Activity Relationship | 1981 |
Sensitivity of 523 blood culture isolates to 33 antibiotics.
Topics: Acinetobacter; Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacteroides; Cephalosporins; Drug Interactions; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pseudomonas; Sepsis; Staphylococcus; Streptococcus | 1984 |
Antimicrobial therapy of infections following abdominal surgery.
Topics: Abdomen; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Chloramphenicol; Clindamycin; Drug Therapy, Combination; Humans; Nitroimidazoles; Penicillins; Postoperative Complications; Sepsis; Surgical Wound Infection | 1984 |
Combination therapy with beta-lactam antibiotics.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Drug Therapy, Combination; Humans; Penicillins; Sepsis | 1983 |
[Pseudomonas aeruginosa bacteriaemia: new clinical and therapeutic aspects ].
Topics: Aged; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Female; Humans; Male; Middle Aged; Penicillins; Prognosis; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis | 1982 |
[Meningitis and sepsis in the newborn age: therapy concepts and antibiotic therapy].
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae Infections; Humans; Infant, Newborn; Infant, Newborn, Diseases; Meningitis; Rabbits; Sepsis | 1983 |
Susceptibility of blood isolates to various antibiotics, in particular to cephalosporins.
Topics: Anti-Bacterial Agents; Bacteria; Cephalosporins; Humans; Microbial Sensitivity Tests; Sepsis | 1983 |
The prevalence of high-level methicillin resistance in multiply resistant hospital staphylococci.
Topics: Cephalosporins; Cross Infection; Humans; Methicillin; Penicillin Resistance; Sepsis; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus | 1981 |
[Treatment of severe infections and septicemia caused by S. aureus (author's transl)].
Topics: Anti-Bacterial Agents; Cefamandole; Cephalosporins; Drug Therapy, Combination; Humans; Oxacillin; Penicillin Resistance; Sepsis; Staphylococcal Infections; Tobramycin; Vancomycin | 1982 |
Antagonism of carbenicillin and cefamandole by cefoxitin in treatment of experimental infections in mice.
Topics: Animals; Bacterial Infections; Carbenicillin; Cefamandole; Cefoxitin; Cephalosporins; Lactams; Male; Mice; Penicillin Resistance; Sepsis | 1982 |
Vitamin K deficiency developing in patients with renal failure treated with cephalosporin antibiotics.
Topics: Adult; Aged; Cephalosporins; Female; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Middle Aged; Sepsis; Urinary Tract Infections; Vitamin K; Vitamin K Deficiency | 1980 |
Cefamandole against Bacteroides fragilis.
Topics: Anti-Bacterial Agents; Bacteria; Bacteroides fragilis; Cefamandole; Cephalosporins; Child; Humans; Sepsis; Species Specificity | 1980 |
[Laboratory and clinical studies of cefmetazole in serious infection by Staphylococcus (author's transl)].
Topics: Aged; Cefmetazole; Cephalosporins; Cephamycins; Child; Child, Preschool; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Male; Meningitis; Sepsis; Staphylococcal Infections; Staphylococcus aureus | 1982 |
Activity of N-formimidoyl thienamycin and cephalosporins against isolates from nosocomially acquired bacteremia.
Topics: Anti-Bacterial Agents; Bacteria; Cephalosporins; Cross Infection; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Sepsis | 1982 |
Evaluation of chemotherapeutic agents in experimental Haemophilus influenzae bacteremia and meningitis in infant rats.
Topics: Ampicillin; Animals; Cefamandole; Cefoxitin; Cephalosporins; Chloramphenicol; Drug Evaluation, Preclinical; Haemophilus influenzae; Meningitis, Haemophilus; Microbial Sensitivity Tests; Rats; Sepsis | 1980 |
Clinical failure of cefamandole in the treatment of Hemophilus influenzae bacteremia.
Topics: Ampicillin; Cefamandole; Cephalosporins; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Penicillin Resistance; Sepsis | 1982 |
Pneumonia and bacteremia caused by a previously undescribed Moraxella-like bacterium.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Humans; Kidney Transplantation; Male; Microbial Sensitivity Tests; Moraxella; Pneumonia; Sepsis | 1982 |
Cefamandole treatment of Salmonella bacteremia.
Topics: Cefamandole; Cephalosporins; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Humans; Salmonella Infections; Salmonella typhi; Sepsis | 1982 |
Clinical study of Rocephin, a 3d generation cephalosporin, in various septicaemias.
Topics: Ceftriaxone; Cephalosporins; Humans; Male; Middle Aged; Sepsis | 1981 |
Bacteroides fragilis septicemia during cefamandole therapy.
Topics: Adult; Bacteroides fragilis; Bacteroides Infections; Cefamandole; Cephalosporins; Female; Humans; Male; Sepsis | 1981 |
[Experience with the therapeutic use of cefuroxime in neonatology].
Topics: Bacterial Infections; Cefuroxime; Cephalosporins; Gastroenteritis; Humans; Infant, Newborn; Infant, Newborn, Diseases; Pyoderma; Respiratory Tract Infections; Sepsis; Urinary Tract Infections | 1981 |
[How many cephalosporins does the clinician need?].
Topics: Cephalosporins; Drug Hypersensitivity; Humans; Penicillins; Sepsis | 1981 |
[Recurrent septicemia with Lancefield-group G streptococci].
Topics: Aged; Cephalosporins; Diabetes Complications; Humans; Male; Penicillin G; Recurrence; Sepsis; Streptococcus | 1980 |
Klebsiella bacteremia.
Topics: Adolescent; Adult; Aged; Aminoglycosides; California; Cephalosporins; Child; Child, Preschool; Cross Infection; Female; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Klebsiella Infections; Male; Middle Aged; Prognosis; Sepsis; Space-Time Clustering | 1980 |
Cefuroxime in soft tissue infections and septicaemia.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefuroxime; Cephalosporins; Drug Tolerance; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Sepsis | 1980 |
Granulocytopenia and septicaemia.
Topics: Agranulocytosis; Cephalosporins; Cephalothin; Humans; Klebsiella Infections; Sepsis | 1980 |
Penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae causing sepsis and meningitis in children with sickle cell disease.
Topics: Anemia, Sickle Cell; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Infant; Male; Meningitis, Bacterial; Penicillins; Salmonella; Sepsis; Serotyping; Streptococcal Infections; Streptococcus pneumoniae | 1995 |
Aeromonas species in septicemia: laboratory characteristics and clinical observations.
Topics: Adolescent; Adult; Aeromonas; Aeromonas hydrophila; Aged; Aged, 80 and over; Animals; Carbenicillin; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Female; Gram-Negative Bacterial Infections; Humans; Infant; Infant, Newborn; Male; Mice; Middle Aged; Sepsis; Serologic Tests; Virulence | 1994 |
Pharmacokinetics of cefepime in patients with the sepsis syndrome.
Topics: Adult; Aged; Aging; Cefepime; Cephalosporins; Chromatography, High Pressure Liquid; Female; Half-Life; Humans; Male; Sepsis; Spectrophotometry, Ultraviolet | 1993 |
Dental care and the prosthetic joint patient: a survey of orthopedic surgeons and general dentists.
Topics: Amoxicillin; Anti-Bacterial Agents; Cephalosporins; Dental Care for Chronically Ill; Dentists; Erythromycin; Humans; Joint Prosthesis; Orthopedics; Patient Care Team; Premedication; Prosthesis-Related Infections; Sepsis; Surveys and Questionnaires | 1994 |
Sputum and serum pharmacokinetics of loracarbef (LY163892) in patients with bronchial sepsis.
Topics: beta-Lactamases; Bronchial Diseases; Cephalosporins; Humans; Sepsis; Sputum | 1995 |
Sepsis due to coryneform group A-4 in an immunocompromised host.
Topics: Actinomycetales; Actinomycetales Infections; Bacteremia; Catheters, Indwelling; Ceftriaxone; Cephalosporins; Humans; Immunocompromised Host; Male; Middle Aged; Sepsis | 1995 |
[Practical use of cefepime in an University hospital. Retrospective study of 35 cases].
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Cefepime; Cephalosporins; Cross Infection; Drug Therapy, Combination; Female; Fluoroquinolones; Glycopeptides; Hospitals, University; Humans; Injections, Intravenous; Lung Diseases; Male; Middle Aged; Neutropenia; Retrospective Studies; Sepsis | 1996 |
[Antimicrobial activities of meropenem against clinically isolated strains. The result against strains isolated from blood and cerebrospinal fluid].
Topics: Ampicillin; Blood; Cefotaxime; Cephalosporins; Cerebrospinal Fluid; Escherichia coli; Humans; Imipenem; Listeria monocytogenes; Meningitis, Bacterial; Meropenem; Penicillins; Sepsis; Streptococcus agalactiae; Streptococcus pneumoniae; Thienamycins | 1996 |
[Antibiotic-induced prolonged cholestasis: suspected induction by ceftibuten].
Topics: Adult; Ceftibuten; Cephalosporin Resistance; Cephalosporins; Cholestasis, Intrahepatic; Fatal Outcome; Female; Humans; Liver; Otitis Externa; Pseudomonas Infections; Sepsis | 1996 |
Catalase-negative Listeria monocytogenes causing lethal sepsis and meningitis in an adult hematologic patient.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Antibodies, Bacterial; Antigens, Bacterial; Blotting, Western; Catalase; Ceftriaxone; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Diagnosis, Differential; Drug Therapy, Combination; Electrophoresis, Polyacrylamide Gel; Female; Humans; Listeria monocytogenes; Lymphoma, T-Cell, Cutaneous; Meningitis, Listeria; Penicillins; Polymerase Chain Reaction; Sepsis; Tobramycin | 1996 |
[Differentiated use of quinolones and cephalosporins].
Topics: Anti-Bacterial Agents; Cephalosporins; Dose-Response Relationship, Drug; Humans; Organ Transplantation; Quinolones; Respiratory Tract Infections; Sepsis | 1995 |
Morganella morganii: a newly reported, rare cause of neonatal sepsis.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Resistance, Multiple; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Infant, Newborn; Male; Microbial Sensitivity Tests; Penicillins; Sepsis | 1997 |
Septicemia as a complication of Henoch-Schönlein purpura.
Topics: Ceftriaxone; Cephalosporins; Child; Duodenal Ulcer; Duodenum; Endoscopy, Gastrointestinal; Enterobacter cloacae; Enterobacteriaceae Infections; Follow-Up Studies; Humans; IgA Vasculitis; Injections, Intravenous; Male; Peptic Ulcer Hemorrhage; Sepsis | 1997 |
Capnocytophaga canimorsus septicemia in an asplenic patient.
Topics: Aged; Animals; Bites and Stings; Capnocytophaga; Cats; Ceftizoxime; Cephalosporins; Diagnosis, Differential; Disease Vectors; Dogs; Female; Gram-Negative Bacterial Infections; Humans; Sepsis | 1997 |
Total knee arthroplasty infections associated with dental procedures.
Topics: Aged; Antibiotic Prophylaxis; Arthritis, Rheumatoid; Arthroplasty, Replacement, Knee; Bacteremia; Cephalosporins; Dental Care; Diabetes Mellitus, Type 1; Disease Susceptibility; Female; Gingival Neoplasms; Humans; Male; Middle Aged; Periodontal Abscess; Periodontal Diseases; Postoperative Care; Premedication; Prosthesis-Related Infections; Referral and Consultation; Retrospective Studies; Risk Factors; Root Canal Therapy; Sepsis; Time Factors; Tooth Extraction; Treatment Outcome | 1997 |
Neonatal sepsis due to nonencapsulated Haemophilus influenzae biotype IV.
Topics: Ampicillin; Bacterial Typing Techniques; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant, Newborn; Male; Meconium Aspiration Syndrome; Oxygen Inhalation Therapy; Penicillins; Pregnancy; Respiratory Insufficiency; Sepsis | 1997 |
Lemierre's syndrome: new insights into an old disease.
Topics: Adolescent; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Drug Therapy, Combination; Female; Fusobacterium Infections; Fusobacterium necrophorum; Humans; Kidney Diseases; Liver Abscess; Lung Diseases; Metronidazole; Nafcillin; Penicillins; Sepsis; Syndrome | 1997 |
The relationship between the use of flucloxacillin, vancomycin, aminoglycosides and ciprofloxacin and the susceptibility patterns of coagulase-negative staphylococci recovered from blood cultures.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Coagulase; Drug Resistance, Microbial; Floxacillin; Humans; Microbial Sensitivity Tests; Penicillins; Sepsis; Streptococcal Infections; Streptococcus; Vancomycin | 1997 |
Primary oligoarthritis in a parent of a child with meningococcal group B sepsis and meningitis.
Topics: Antibiotics, Antitubercular; Arthritis, Infectious; Ceftriaxone; Cephalosporins; Female; Follow-Up Studies; Humans; Infant; Male; Meningitis, Meningococcal; Rifampin; Sepsis | 1998 |
[Use of sodium ceftiofur in the combined therapy of complicated septic diseases in cattle].
Topics: Animals; Arthritis, Infectious; Cattle; Cattle Diseases; Cephalosporins; Combined Modality Therapy; Female; Hoof and Claw; Joint Diseases; Nail Diseases; Sepsis | 1998 |
Clinical outcome of cephalothin versus vancomycin therapy in the treatment of coagulase-negative staphylococcal septicemia in neonates: relation to methicillin resistance and mec A gene carriage of blood isolates.
Topics: Anti-Bacterial Agents; Cephalosporins; Cephalothin; Coagulase; Genes, Bacterial; Humans; Infant; Infant, Newborn; Methicillin Resistance; Retrospective Studies; Sepsis; Staphylococcal Infections; Staphylococcus; Vancomycin | 1999 |
Subcutaneous nodules with pseudomonas septicaemia in an immunocompetent patient.
Topics: Adult; Ceftazidime; Cephalosporins; Community-Acquired Infections; Female; Gentamicins; Humans; Immunocompetence; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Skin Diseases, Bacterial | 1999 |
[Effectiveness and disposition of the newly developed cephalosporin cefquinome in puerperal septicemia and toxemia in gilts].
Topics: Amoxicillin; Animals; Cephalosporins; Endometritis; Female; Microbial Sensitivity Tests; Puerperal Disorders; Sepsis; Swine; Swine Diseases; Syndrome; Toxemia | 1999 |
Cyclosporine treatment of psoriatic erythroderma complicated by bacterial sepsis.
Topics: Acitretin; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Cyclosporine; Dermatitis, Exfoliative; Dermatologic Agents; Humans; Immunosuppressive Agents; Keratolytic Agents; Male; Middle Aged; Psoriasis; Sepsis; Staphylococcal Infections; Streptococcal Infections; Vancomycin | 1999 |
Survival following group A streptococcal septicaemia in a centenarian.
Topics: Administration, Oral; Aged; Aged, 80 and over; Amoxicillin; Cefuroxime; Cephalosporins; Female; Humans; Injections, Intravenous; Penicillins; Sepsis; Streptococcal Infections; Streptococcus pyogenes; Treatment Outcome; United Kingdom | 1999 |
Antimicrobial therapy for serious bacterial infections in children in a primary care setting--a poll of experts.
Topics: Amoxicillin; Bacterial Infections; Ceftriaxone; Cephalosporins; Child, Preschool; Dysentery; Humans; Infant; Meningitis; Penicillins; Pneumonia; Practice Patterns, Physicians'; Primary Health Care; Sepsis | 1999 |
Clinical problem-solving. Chest pain with a surprising course.
Topics: Aged; Anuria; Cefuroxime; Cephalosporins; Chest Pain; Cholecystitis; Clostridium Infections; Clostridium perfringens; Coombs Test; Coronary Disease; Diabetes Mellitus, Type 1; Diagnosis, Differential; Emphysema; Hemolysis; Humans; Liver Function Tests; Male; Myocardial Ischemia; Renal Insufficiency; Sepsis | 1999 |
Septicemia in neutropenic patients infected with Clostridium tertium resistant to cefepime and other expanded-spectrum cephalosporins.
Topics: Aged; Anti-Bacterial Agents; Cefepime; Cephalosporin Resistance; Cephalosporins; Clostridium; Clostridium Infections; Humans; Male; Middle Aged; Neutropenia; Opportunistic Infections; Sepsis; Vancomycin | 1999 |
[The effect of the regimen for administering antibacterial therapy on the manifestations of endogenous intoxication in patients operated on for lung cancer].
Topics: Antibiotic Prophylaxis; Biomarkers; Cefotaxime; Cephalosporins; Humans; Lung Neoplasms; Malondialdehyde; Postoperative Care; Preoperative Care; Retrospective Studies; Sepsis; Superoxide Dismutase; Time Factors | 1999 |
Ischaemic hepatitis in an elderly woman.
Topics: Aged; Alanine Transaminase; Aspartate Aminotransferases; Bacteremia; Ceftriaxone; Cephalosporins; Female; Hepatitis; Humans; Ischemia; L-Lactate Dehydrogenase; Liver; Sepsis; Staphylococcal Infections | 1999 |
Rationing antibiotic use in neonatal units.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Decision Making; Drug Resistance, Microbial; Floxacillin; Health Care Rationing; Humans; Infant, Newborn; Intensive Care, Neonatal; Penicillins; Sepsis; Vancomycin | 2000 |
Pharmacokinetics of cefpirome in critically ill patients with renal failure treated by continuous veno-venous hemofiltration.
Topics: Aged; APACHE; Cefpirome; Cephalosporins; Critical Care; Female; Hemofiltration; Humans; Infusions, Intravenous; Male; Middle Aged; Multiple Organ Failure; Renal Insufficiency; Sepsis; Serum Bactericidal Test | 1999 |
Differential host inflammatory responses to viable versus antibiotic-killed bacteria in experimental microbial sepsis.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Ceftazidime; Cell Adhesion; Cell Movement; Cephalosporins; Dexamethasone; Endothelium, Vascular; Escherichia coli; Female; Galactosamine; Imipenem; Kinetics; Leukocytes; Male; Mice; Microcirculation; Rats; Rats, Sprague-Dawley; Sepsis; Staphylococcus aureus; Thienamycins; Time Factors; Tumor Necrosis Factor-alpha | 2000 |
An antibiotic policy to prevent emergence of resistant bacilli.
Topics: Amoxicillin; Cefotaxime; Cephalosporins; Cross-Sectional Studies; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Organizational Policy; Penicillins; Prospective Studies; Sepsis | 2000 |
Pulmonary complications in patients with staphylococcal sepsis.
Topics: Adolescent; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Lung Diseases; Male; Pleurisy; Pneumonia, Staphylococcal; Pneumothorax; Retrospective Studies; Sepsis; Staphylococcal Infections | 2000 |
Neonatal sepsis workups in infants >/=2000 grams at birth: A population-based study.
Topics: Ampicillin; Bacteriological Techniques; Cephalosporins; Evidence-Based Medicine; Follow-Up Studies; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature, Diseases; Patient Readmission; Prospective Studies; Risk Factors; Sepsis; Streptococcal Infections; Streptococcus agalactiae | 2000 |
[The influence of severe infections on the natural killer cells in neonates with vary gestational age].
Topics: Antibodies, Monoclonal; Antigens, CD; Cephalosporins; Female; Humans; Infant, Newborn; Killer Cells, Natural; Male; Meningitis, Bacterial; Pneumonia, Bacterial; Sepsis; Severity of Illness Index; Treatment Outcome | 2000 |
Effect of ceftazidime on systemic cytokine concentrations in rats.
Topics: Animals; Ceftazidime; Cephalosporins; Cytokines; Interleukin-6; Rats; Sepsis; Tumor Necrosis Factor-alpha | 2000 |
SAR studies of anti-MRSA non-zwitterionic 3-heteroarylthiocephems.
Topics: Animals; Blood Proteins; Cephalosporins; Humans; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship | 2000 |
In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci.
Topics: Abscess; Animals; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cephalosporins; Disease Models, Animal; Enzyme Stability; Hexosyltransferases; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Sepsis; Staphylococcus aureus; Substrate Specificity | 2001 |
[Nosocomial enterobacter - sepsis in neonatal intensive care unit in Pleven].
Topics: Bulgaria; Cephalosporin Resistance; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Enterobacter aerogenes; Enterobacteriaceae Infections; Female; Humans; Hygiene; Incidence; Infant, Newborn; Infection Control; Intensive Care Units, Neonatal; Pregnancy; Retrospective Studies; Sepsis; Workforce | 2000 |
Active immunization with a detoxified Escherichia coli J5 lipopolysaccharide group B meningococcal outer membrane protein complex vaccine protects animals from experimental sepsis.
Topics: Animals; Antibodies, Bacterial; Bacterial Outer Membrane Proteins; Ceftazidime; Cephalosporins; Cyclophosphamide; Disease Models, Animal; Disease-Free Survival; Endotoxins; Escherichia coli; Escherichia coli Vaccines; Female; Klebsiella pneumoniae; Lipopolysaccharides; Neisseria meningitidis; Neutropenia; Pseudomonas aeruginosa; Rats; Rats, Sprague-Dawley; Sepsis; Vaccines, Conjugate | 2001 |
Prediction of in-vivo efficacy by in-vitro early bactericidal activity with oral beta-lactams, in a dose-ranging immunocompetent mouse sepsis model, using strains of Streptococcus pneumoniae with decreasing susceptibilities to penicillin.
Topics: Amoxicillin; Animals; Area Under Curve; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalosporins; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Forecasting; Mice; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pneumococcal Infections; Predictive Value of Tests; Sepsis; Streptococcus pneumoniae | 2001 |
Low cefpirome levels during twice daily dosing in critically ill septic patients: pharmacokinetic modelling calls for more frequent dosing.
Topics: Adult; Aged; APACHE; Area Under Curve; Cefpirome; Cephalosporins; Critical Illness; Female; Half-Life; Humans; Infusions, Intravenous; Intensive Care Units; Male; Middle Aged; Prospective Studies; Sepsis; Treatment Outcome | 2001 |
Lipopolyamines as a therapeutic strategy in experimental Gram-negative bacterial sepsis.
Topics: Animals; Bacteremia; Ceftazidime; Cephalosporins; Disease Models, Animal; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Gram-Negative Bacterial Infections; Neutropenia; Rats; Sepsis; Survival Analysis | 2001 |
Retroperitoneal sepsis complicating stapled hemorrhoidectomy: report of a case and review of the literature.
Topics: Adult; Anti-Infective Agents; Cefuroxime; Cephalosporins; Hemorrhoids; Humans; Male; Metronidazole; Postoperative Complications; Retroperitoneal Space; Sepsis; Sutures | 2002 |
Meningococcal disease presenting as bronchiolitis.
Topics: Bronchiolitis; Cefotaxime; Cephalosporins; Diagnosis, Differential; Humans; Infant; Male; Meningococcal Infections; Neisseria meningitidis; Penicillin G; Penicillins; Sepsis | 2002 |
Letter: Intravenous cephradine in serious paediatric infections.
Topics: Bacterial Infections; Cellulitis; Cephalosporins; Child; Cyclohexanes; Humans; Infant; Infant, Newborn; Pneumonia; Pneumonia, Pneumococcal; Sepsis; Staphylococcal Infections; Streptococcal Infections; Umbilicus | 1975 |
Cefotaxime and nephrotoxicity.
Topics: Cephalosporins; Drug Evaluation; Enterobacteriaceae Infections; Humans; Kidney; Sepsis; Urinary Tract Infections | 1979 |
Antibiotic treatment of respiratory sepsis.
Topics: Ampicillin; Anti-Bacterial Agents; Carbenicillin; Cephalosporins; Chloramphenicol; Cloxacillin; Fosfomycin; Gentamicins; Haemophilus Infections; Humans; Methicillin; Penicillin G; Polymyxins; Pseudomonas Infections; Respiratory Tract Infections; Sepsis; Staphylococcal Infections; Streptococcal Infections | 1976 |
Chemotherapy and renal function.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Colistin; Humans; Kidney; Kidney Function Tests; Penicillins; Polymyxins; Sepsis; Tetracyclines; Urinary Tract Infections | 1976 |
[Azlocilline and HR 756 in urosepsis and urinary tract infection with multiresistant pseudomonas and proteus morganii].
Topics: Adolescent; Cephalosporins; Female; Humans; Penicillin Resistance; Penicillins; Proteus Infections; Pseudomonas Infections; Sepsis; Tobramycin; Urinary Tract Infections | 1979 |
Efficacy and safety of cefamandole plus either gentamicin or tobramycin in therapy of severe gram-negative bacterial infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cefamandole; Cephalosporins; Drug Therapy, Combination; Endometritis; Escherichia coli Infections; Female; Gentamicins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia; Proteus Infections; Proteus vulgaris; Pyelonephritis; Sepsis; Tobramycin | 1978 |
[Increasing incidence of Serratia marcescens bacteraemia in intensive care patients (author's transl)].
Topics: Adolescent; Adult; Aged; Austria; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae Infections; Gentamicins; Humans; Intensive Care Units; Middle Aged; Retrospective Studies; Sepsis; Serratia marcescens | 1978 |
Therapy of serious infections with cefamandole.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefamandole; Cephalosporins; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Middle Aged; Sepsis; Staphylococcal Infections; Streptococcal Infections | 1978 |
[New antibiotics].
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Cephalosporins; Escherichia coli Infections; Gram-Negative Aerobic Bacteria; Humans; Klebsiella Infections; Penicillin Resistance; Penicillins; Pseudomonas Infections; Sepsis | 1979 |
[Laboratory and clinical studies on cefuroxime (author's transl)].
Topics: Adolescent; Bacterial Infections; Cefuroxime; Cephalosporins; Child; Child, Preschool; Common Bile Duct Diseases; Cysts; Drug Resistance, Microbial; Escherichia coli; Female; Humans; Infant; Klebsiella pneumoniae; Lymphadenitis; Male; Microbial Sensitivity Tests; Pneumonia; Sepsis; Staphylococcus aureus | 1979 |
Antimicrobial synergism in the therapy of gram-negative rod bacteremia.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Carbenicillin; Cephalosporins; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Proteus; Pseudomonas aeruginosa; Sepsis; Serratia marcescens | 1978 |
[Artificial respiration and infection in postoperative intensive care].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Humans; Penicillins; Pneumonia; Postoperative Care; Postoperative Complications; Respiration, Artificial; Sepsis | 1979 |
Carbenicillin plus cefamandole in the treatment of infections in patients with cancer.
Topics: Adolescent; Aeromonas; Aged; Bacterial Infections; Carbenicillin; Cefamandole; Cephalosporins; Corynebacterium Infections; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Flavobacterium; Humans; Listeriosis; Male; Middle Aged; Neoplasms; Respiratory Tract Infections; Sepsis; Tobramycin | 1978 |
Persistent bacteremia in staphylococcal endocarditis.
Topics: Adult; Aged; Cephalosporins; Clindamycin; Drug Resistance, Microbial; Endocarditis, Bacterial; Female; Humans; Male; Middle Aged; Penicillin Resistance; Sepsis; Staphylococcal Infections; Vancomycin | 1978 |
[Treatment of septicemia and severe infections with a cefradine-tobramycin combination].
Topics: Adult; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cephalosporins; Cephradine; Drug Combinations; Humans; Kidney; Sepsis; Tobramycin | 1976 |
Management of anaerobic infections.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacterial Infections; Bacteroides Infections; Bone Diseases; Brain Abscess; Cephalosporins; Clindamycin; Female; Genital Diseases, Female; Humans; Infections; Joint Diseases; Lung Abscess; Lung Diseases; Male; Metronidazole; Penicillin G; Penicillins; Sepsis; Tetracyclines | 1975 |
Evaluation of antimicrobial agents in the treatment of septicemia (lecture).
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Carbenicillin; Cephalosporins; Chloramphenicol; Clindamycin; Cloxacillin; Dicloxacillin; Humans; Methicillin; Nafcillin; Oxacillin; Penicillin G; Penicillin Resistance; Sepsis; Tetracyclines | 1976 |
Therapy of Staphylococcus aureus bacteremia associated with a removable focus of infection.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Female; Focal Infection; Follow-Up Studies; Humans; Infant; Infant, Newborn; Male; Middle Aged; Penicillins; Sepsis; Staphylococcal Infections; Time Factors | 1976 |
[Therapeutic effects of a combination treatment with flomoxef and tobramycin against infections complicated with hematological disorders].
Topics: Adult; Aged; Cephalosporins; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Immunocompromised Host; Infusions, Intravenous; Male; Middle Aged; Neutropenia; Opportunistic Infections; Sepsis; Tobramycin | 1992 |
[Countermeasure for infections with granulocytopenia].
Topics: Agranulocytosis; Aminoglycosides; Anti-Bacterial Agents; Candidiasis; Cephalosporins; Drug Therapy, Combination; Fluconazole; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Miconazole; Pneumonia; Recombinant Proteins; Risk Factors; Sepsis | 1992 |
Antibacterial properties of Ro 40-6890, a broad-spectrum cephalosporin, and its novel orally absorbable ester, Ro 41-3399.
Topics: Animals; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cephalosporins; Gram-Negative Aerobic Bacteria; Hexosyltransferases; Hydrolysis; Intestinal Absorption; Mice; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Protein Binding; Sepsis | 1992 |
RU 29 246, the active compound of the cephalosporin prodrug-ester HR 916. III. Pharmacokinetic properties and antibacterial activity in vivo.
Topics: Animals; Cephalosporins; Dogs; Female; Male; Mice; Pneumonia; Prodrugs; Rats; Rats, Inbred Strains; Sepsis; Tissue Distribution | 1992 |
[Complication of liver cirrhosis and the counter measures].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Humans; Kupffer Cells; Liver Cirrhosis; Peritonitis; Peritonitis, Tuberculous; Phagocytosis; Sepsis | 1991 |
Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Analysis of Variance; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacter; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Sepsis | 1991 |
In vitro and in vivo evaluation of Ro 09-1428, a new parenteral cephalosporin with high antipseudomonal activity.
Topics: Animals; Bacteria; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Ceftazidime; Cephalosporins; Hexosyltransferases; Mice; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Protein Binding; Pseudomonas aeruginosa; Sepsis | 1991 |
[Five cases of listeriosis in the elderly].
Topics: Age Factors; Aged; Aged, 80 and over; Cephalosporins; Drug Resistance, Microbial; Female; Food Microbiology; Histamine H2 Antagonists; Humans; Listeria monocytogenes; Listeriosis; Male; Meningitis, Listeria; Prednisolone; Sepsis; Time Factors | 1990 |
Antibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome (HR 111V), a new broad-spectrum cephalosporin.
Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Proteins; beta-Lactamases; Blood Proteins; Carrier Proteins; Cattle; Cephalosporins; Culture Media; Dogs; Enzyme Stability; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Hexosyltransferases; Horses; Hydrogen-Ion Concentration; Male; Mice; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Sepsis; Swine | 1991 |
Bacterial infections in the newborn infant.
Topics: Ampicillin; Bacterial Infections; Cephalosporins; Drug Therapy, Combination; Gentamicins; Humans; Infant, Newborn; Risk Factors; Sepsis | 1991 |
Antibiotic susceptibility of 629 bacterial blood and CSF isolates from Swedish infants and the therapeutic implications.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Bacteria; Blood; Cephalosporins; Cerebrospinal Fluid; Drug Resistance, Microbial; Humans; Infant; Infant, Newborn; Meningitis; Sepsis; Sweden | 1991 |
[Empirical treatment of febrile episodes in patients with neutropenia in bone marrow transplantation].
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Bone Marrow Transplantation; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Humans; Male; Neutropenia; Premedication; Retrospective Studies; Sepsis; Ticarcillin; Trimethoprim, Sulfamethoxazole Drug Combination | 1990 |
Comparative in vitro activity of the new quinolone sparfloxacin (CI-978, AT-4140) against nosocomial gram-negative bloodstream isolates.
Topics: Amikacin; Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Cross Infection; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Bacteria; Humans; Imipenem; Pseudomonas aeruginosa; Sepsis; Tobramycin | 1990 |
Toxic pustuloderma: a self-limiting eruption.
Topics: Adult; Cephalosporins; Drug Eruptions; Erythema; Female; Foodborne Diseases; Humans; Male; Middle Aged; Sepsis; Skin Diseases, Vesiculobullous | 1990 |
Prevalence of antibiotic-resistant uropathogens in obstetric patients with acute pyelonephritis.
Topics: Acute Disease; Ampicillin; Cephalosporins; Drug Resistance, Microbial; Female; Humans; Incidence; Microbial Sensitivity Tests; Pregnancy; Pregnancy Complications, Infectious; Pyelonephritis; Sepsis; Shock, Septic; Urine | 1990 |
Comparative chemotherapeutic activity of cefpirome and imipenem in experimental infections.
Topics: Abscess; Animals; Bacterial Infections; Cefotaxime; Cefpirome; Cephalosporins; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Granuloma; Imipenem; Male; Mice; Mice, Hairless; Mice, Inbred C3H; Pneumonia; Rats; Rats, Inbred Strains; Sepsis; Staphylococcal Skin Infections; Staphylococcus aureus; Streptococcal Infections | 1990 |
[A case of pneumococcal arthritis in a patient with gout].
Topics: Arthritis, Infectious; Cephalosporins; Gout; Humans; Male; Middle Aged; Penicillin G; Pneumonia; Sepsis; Streptococcal Infections; Streptococcus pneumoniae | 1989 |
[Diseases caused by group G beta-hemolytic streptococci].
Topics: Adult; Cephalosporins; Endometritis; Female; Humans; Infant, Newborn; Male; Meningitis; Penicillin G; Pregnancy; Puerperal Disorders; Sepsis; Streptococcal Infections; Streptococcus | 1989 |
Prophylactic antibiotic coverage in patients with total arthroplasty: current practice.
Topics: Anti-Bacterial Agents; Arthritis, Infectious; Cephalosporins; Dental Care for Disabled; Humans; Joint Prosthesis; Penicillins; Premedication; Sepsis | 1985 |
Incidence of inducible beta-lactamases in gram-negative septicemia isolates from twenty-nine European laboratories. European Study Group on Antibiotic Resistance.
Topics: Amdinocillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporins; Citrobacter; Enzyme Induction; Gram-Negative Bacteria; Humans; Lactams; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Sepsis | 1987 |
[Enterobacter cloacae and E. aerogenes septicemia: emergence of resistant variants (derepressed cephalosporinase) during treatment with third-generation cephalosporins].
Topics: Adult; Aged; beta-Lactamases; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Mutation; Sepsis | 1985 |
Enterobacter cloacae bacteremia: clinical analysis of 41 cases.
Topics: Adult; Cephalosporins; Cross Infection; Enterobacter; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Sepsis | 1988 |
Haemophilus influenzae neonatal sepsis--what is appropriate initial therapy?
Topics: Adult; Ampicillin; Cephalosporins; Drug Resistance, Microbial; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant, Newborn; Pregnancy; Sepsis | 1988 |
Therapeutic efficacy of chloramphenicol, co-trimoxazole (trimethoprim/sulphamethoxazole), cefmenoxime and ceftriaxone in experimental bacteraemia and meningitis caused by ampicillin-resistant Haemophilus influenzae type b.
Topics: Ampicillin Resistance; Anti-Infective Agents; Cefmenoxime; Ceftriaxone; Cephalosporins; Chloramphenicol; Colony Count, Microbial; Drug Combinations; Humans; Infant; Male; Meningitis, Haemophilus; Sepsis; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
Alterations of pharmacokinetic characteristics of antibiotics during sepsis: experimental and clinical data.
Topics: Animals; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Humans; Longitudinal Studies; Netilmicin; Rabbits; Sepsis | 1987 |
Bacteremia complicating acute leukemia with special reference to its incidence and changing etiological patterns.
Topics: Acute Disease; Adolescent; Adult; Aged; Bacteria; Cephalosporins; Child; Cross Infection; Female; Humans; Leukemia; Male; Middle Aged; Sepsis; Serotyping | 1988 |
Antibiotic susceptibility of Haemophilus influenzae isolated from cerebrospinal fluid and blood.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Ceftriaxone; Cephalosporins; Cerebrospinal Fluid; Chloramphenicol; Drug Resistance, Microbial; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Netilmicin; Rifampin; Sepsis | 1986 |
Cephalosporin therapy for salmonellosis. Questions of efficacy and cross resistance with ampicillin.
Topics: Ampicillin; beta-Lactamases; Cephalosporins; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Salmonella; Salmonella Infections; Sepsis | 1986 |
The efficacy of amikacin in the treatment of severe infections in a renal unit.
Topics: Amikacin; Bacteria; Bacterial Infections; Cephalosporins; Drug Therapy, Combination; Female; Hospital Units; Humans; Kidney Diseases; Male; Middle Aged; Penicillins; Sepsis | 1987 |
[Cephalosporins: microbiological and pharmacokinetic properties, application to pediatrics].
Topics: Bacteria; Bacterial Infections; Cephalosporins; Child; Half-Life; Humans; Meningitis; Metabolic Clearance Rate; Pneumonia; Sepsis; Urinary Tract Infections | 1987 |
Alterations of pharmacokinetic properties of gentamicin, penicillin G and two cephalosporins in septicaemic rabbits.
Topics: Animals; Cephalosporins; Gentamicins; Male; Moxalactam; Penicillin G; Rabbits; Sepsis | 1987 |
Antibiotic cost savings from formulary restrictions and physician monitoring in a medical-school-affiliated hospital.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Cost Control; Costs and Cost Analysis; Drug Utilization; Formularies, Hospital as Topic; Hospital Bed Capacity, 500 and over; Hospitals, Teaching; Humans; Missouri; Pharmacy Service, Hospital; Regression Analysis; Retrospective Studies; Sepsis; Vancomycin | 1987 |
Influence of endotoxin on the distribution of cephalosporins in rabbits.
Topics: Animals; Body Temperature; Cephalosporins; Endotoxins; Injections, Intravenous; Kinetics; Rabbits; Sepsis | 1986 |
[Septicemia of children in Japan (1980-1984). Part 3. Antibiotic therapy and prognosis].
Topics: Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Gentamicins; Humans; Infant; Infant, Newborn; Japan; Male; Penicillins; Prognosis; Sepsis | 1986 |
[Septicemia of children in Japan (1980-1984). Part 4. Antibiotic treatment and prognosis according to causative agents].
Topics: Aminoglycosides; Ampicillin; Cephalosporins; Child; Child, Preschool; Humans; Infant; Infant, Newborn; Japan; Penicillins; Prognosis; Sepsis | 1986 |
Cefuroxime therapy for bacteremic soft-tissue infections in children.
Topics: beta-Lactamases; Cefuroxime; Cellulitis; Cephalosporins; Child, Preschool; Drug Resistance, Microbial; Epiglottitis; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Laryngitis; Male; Penicillin Resistance; Pneumococcal Infections; Sepsis; Staphylococcal Infections | 1985 |
Efficacy of BMY-28142 in experimental bacteremia and meningitis caused by Escherichia coli and group B streptococci.
Topics: Animals; Cefepime; Cefotaxime; Cephalosporins; Escherichia coli; Female; Meningitis; Microbial Sensitivity Tests; Penicillin G; Pregnancy; Rats; Rats, Inbred Strains; Sepsis; Streptococcal Infections; Streptococcus agalactiae | 1985 |
Comparative activity of seven extended-spectrum cephalosporins against gram-negative bacilli from blood cultures.
Topics: Cefmenoxime; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis | 1985 |
Resistance to beta-lactamase-stable cephalosporin antibiotics in strains of Enterobacteriaceae and Pseudomonas aeruginosa isolated from blood cultures.
Topics: beta-Lactamases; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Humans; Pseudomonas aeruginosa; Sepsis | 1985 |
Enterococcal bacteremia in surgical patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Catheterization; Cephalosporins; Digestive System Surgical Procedures; Female; Humans; Male; Middle Aged; Postoperative Complications; Risk; Sepsis; Streptococcal Infections | 1985 |
Use of aminoglycosides in immunocompromised patients.
Topics: Agranulocytosis; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Immune Tolerance; Infusions, Parenteral; Kidney Diseases; Microbial Sensitivity Tests; Neutropenia; Pseudomonas Infections; Sepsis | 1985 |
Pharmacokinetics of cephalosporins in normal and septicemic rabbits.
Topics: Animals; Biological Assay; Blood Proteins; Cephalosporins; Drug Implants; Kinetics; Male; Protein Binding; Rabbits; Sepsis | 1985 |
[Use of antibiotics in septic surgery].
Topics: Anti-Bacterial Agents; Burns; Cephalosporins; Chloramphenicol; Dihydrostreptomycin Sulfate; Empyema; Gentamicins; Humans; Infections; Osteomyelitis; Penicillin Resistance; Penicillins; Sepsis; Streptomycin; Surgical Wound Infection; Tetracycline | 1971 |
Therapeutic implications of interaction of gentamicin and penicillins.
Topics: Ampicillin; Cephaloridine; Cephalosporins; Cephalothin; Cloxacillin; Drug Interactions; Drug Synergism; Gentamicins; Humans; Injections, Intramuscular; Injections, Intravenous; Methicillin; Penicillins; Sepsis | 1971 |
Evaluation of cefazolin in the treatment of bacterial endocarditis and bacteremia.
Topics: Adult; Aged; Cephalosporins; Drug Evaluation; Endocarditis, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Micrococcus; Middle Aged; Sepsis; Staphylococcal Infections; Staphylococcus; Streptococcal Infections; Streptococcus; Streptococcus pneumoniae; Sulfides; Tetrazoles; Thiadiazoles | 1973 |
Infections in heroin addicts.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Microbial; Endocarditis, Bacterial; Humans; Kanamycin; Morphine Dependence; Sepsis; Staphylococcal Infections; Vancomycin | 1967 |
Diagnosis and management of infections associated with immunosuppression. New antibiotics of potential importance for immunosuppressed patients.
Topics: Amino Sugars; Bacteria; Carbenicillin; Cephalexin; Cephaloridine; Cephalosporins; Cephalothin; Escherichia coli Infections; Glycosides; Immunization, Passive; Immunosuppression Therapy; Kanamycin; Penicillin Resistance; Penicillins; Proteus Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Structure-Activity Relationship | 1973 |
Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsis.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Bacteria; Bacteriuria; Cephalosporins; Escherichia coli; Female; Gentamicins; Humans; Infant; Klebsiella; Male; Microbial Sensitivity Tests; Middle Aged; Monitoring, Physiologic; Pneumonia; Proteus mirabilis; Pseudomonas aeruginosa; Sepsis; Urinary Tract Infections; Wound Infection | 1974 |
Antibacterial action of "broad-spectrum" penicillins, cephalosporins and other antibiotics against Gram-negative bacilli isolated from bacteremic patients.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteriuria; Cephalosporins; Cephalothin; Chloramphenicol; Chlortetracycline; Demeclocycline; Escherichia coli; Gentamicins; Humans; Kanamycin; Klebsiella; Methacycline; Microbial Sensitivity Tests; Oxytetracycline; Penicillin G; Penicillins; Polymyxins; Proteus; Pseudomonas aeruginosa; Sepsis; Serratia; Streptomycin; Tetracycline | 1967 |
[Prevention of infectious complications of acute leukemias: place of general and intestinal antibiotic therapy].
Topics: Administration, Oral; Ampicillin; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Humans; Infection Control; Infections; Leukemia; Nystatin; Sepsis | 1973 |
[Clinical study on the new derivative of cephalosporine called cefradine].
Topics: Adolescent; Adult; Aged; Blood Chemical Analysis; Cephalosporins; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Male; Middle Aged; Osteomyelitis; Peritonitis; Pneumonia; Sepsis | 1974 |
Cephacetrile--a new cephalosporin antibiotic.
Topics: Acetamides; Adult; Cephalosporins; Female; Furosemide; Humans; Injections, Intramuscular; Injections, Intravenous; Male; Nitriles; Pneumonia; Respiratory Tract Infections; Sepsis; Urinary Tract Infections | 1974 |
The cephalosporin antibiotics in clinical medicine.
Topics: Adult; Bacterial Infections; Cephalexin; Cephaloridine; Cephalosporins; Cephalothin; Child; Dentistry, Operative; Drug Hypersensitivity; Gonorrhea; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Middle Aged; Penicillin Resistance; Penicillins; Rheumatic Heart Disease; Sepsis; Staphylococcal Infections; Syphilis | 1973 |
Staphylococcus aureus bacteremia: A critical review of its treatment and association with infective endocarditis.
Topics: Adult; Aged; Blood; Cephalosporins; Cephalothin; Child; Cloxacillin; Endocarditis, Bacterial; Female; Gentamicins; Heart Auscultation; Hospitalization; Humans; Kanamycin; Male; Methicillin; Middle Aged; Penicillin Resistance; Penicillins; Prostheses and Implants; Recurrence; Sepsis; Staphylococcal Infections; Time Factors | 1973 |
Haemophilus influenzae.
Topics: Adult; Ampicillin; Cephalosporins; Child; Child, Preschool; Chloramphenicol; Drug Combinations; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Male; North America; Penicillin Resistance; Respiratory Tract Infections; Sepsis; Sulfamethoxazole; Tetracycline; Trimethoprim; United Kingdom; United States | 1974 |
Generalised gram-negative bacillary infections.
Topics: Ampicillin; Bacillus; Bacterial Infections; Bacteriological Techniques; Carbenicillin; Cephalosporins; Cross Infection; Humans; Penicillins; Sepsis | 1972 |
Antibacterial therapy in childhood.
Topics: Anti-Bacterial Agents; Cephalosporins; Child; Diarrhea; Drug Resistance, Microbial; Escherichia coli Infections; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Meningitis; Respiratory Tract Infections; Sepsis; Staphylococcal Infections; Urinary Tract Infections | 1973 |
[Urosepsis in urinary calculi].
Topics: Adult; Ampicillin; Carbenicillin; Cephalosporins; Drug Therapy, Combination; Escherichia coli Infections; Female; Gentamicins; Humans; Klebsiella Infections; Male; Nephrectomy; Proteus Infections; Pseudomonas Infections; Sepsis; Urinary Calculi | 1974 |
Cephacetrile--a new cephalosporin antibiotic.
Topics: Adult; Bacterial Infections; Cephalosporins; Drug Interactions; Female; Furosemide; Humans; Injections, Intramuscular; Injections, Intravenous; Kidney; Male; Microbial Sensitivity Tests; Pneumonia; Proteus; Proteus Infections; Pseudomonas; Pseudomonas Infections; Respiratory Tract Infections; Sepsis; Urinary Tract Infections | 1973 |
[Clinical incidence of heterogenous resistance of Staphylococcus to penicillin and cephalosporin].
Topics: Cephalosporins; Cross Infection; Female; Humans; Methicillin; Oxacillin; Penicillin Resistance; Sepsis; Staphylococcal Infections; Staphylococcus | 1967 |
Methicillin-resistant staphylococcemia: bacteriological failure of treatment with cephalosporins.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; Cephalosporins; Cross Infection; Humans; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Sepsis; Staphylococcal Infections; Staphylococcus | 1970 |
[The importance of streptococcal research for clinical practice. (With reference to new therapeutic possibilities)].
Topics: Administration, Oral; Cephalosporins; Humans; Infant; Infant, Newborn; Lincomycin; Penicillin V; Penicillins; Sepsis; Streptococcal Infections; Streptococcus | 1970 |
Antibiotics 1971.
Topics: Adult; Anti-Bacterial Agents; Antiviral Agents; Catheterization; Cephalosporins; Endocarditis, Bacterial; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Infant, Newborn; Infant, Newborn, Diseases; Lincomycin; Mycoses; Penicillins; Pregnancy; Sepsis; Staphylococcal Infections; Umbilicus | 1971 |
Neonatal bacteremia.
Topics: Administration, Oral; Catheterization; Cephalosporins; Humans; Infant, Newborn; Infant, Newborn, Diseases; Sepsis; Umbilical Cord | 1971 |
[Purulent pericarditis].
Topics: Ampicillin; Cephalosporins; Child, Preschool; Female; Gentamicins; Humans; Kanamycin; Lincomycin; Methicillin; Osteomyelitis; Penicillin G; Pericarditis; Prednisone; Sepsis; Streptokinase; Strophanthins; Suppuration | 1971 |
[Clinical pharmacologic studies of cephalexin. Influence of renal insufficiency, with or without hemodialytic treatment, on plasma levels. Effectiveness in urinary infection].
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Bacterial Infections; Cephalexin; Cephalosporins; Child; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Middle Aged; Sepsis; Urinary Tract Infections | 1971 |
Staphylococcal infections in nurseries.
Topics: Ampicillin; Bacitracin; Cephalosporins; Chloramphenicol; Cross Infection; Erythromycin; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature, Diseases; Methicillin; Novobiocin; Penicillin G; Sepsis; Tetracycline; Troleandomycin; Vancomycin | 1966 |
[A case of severe staphylococcal septicemia treated with semisynthetic antibiotic ceporin].
Topics: Adolescent; Cephalosporins; Humans; Male; Sepsis; Staphylococcal Infections | 1969 |
Cephalexin--a new oral cephalosporin: clinical evaluation in sixty-three patients.
Topics: Adolescent; Adult; Aged; Bronchitis; Cephalosporins; Cephalothin; Drug Resistance, Microbial; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Pharyngitis; Pneumococcal Infections; Pneumonia; Pneumonia, Staphylococcal; Prostatitis; Sepsis; Staphylococcal Infections; Streptococcal Infections; Urinary Tract Infections | 1970 |
Clinicolaboratory experience with cephalexin.
Topics: Adolescent; Adult; Aged; Cephalosporins; Child; Child, Preschool; Endocarditis, Bacterial; Humans; Infant; Middle Aged; Respiratory Tract Infections; Sepsis; Urinary Tract Infections | 1970 |
Infections caused by unusual beta hemolytic streptococci.
Topics: Abscess; Adolescent; Adult; Aged; Ampicillin; Cephalosporins; Child; Child, Preschool; Female; Humans; Kanamycin; Male; Middle Aged; Oxacillin; Penicillins; Pericarditis; Sepsis; Streptococcal Infections; Streptococcus; Streptomycin; Wound Infection | 1971 |
Use of cephalosporins in the treatment of Gram-negative bacillary bacteremia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Cross Infection; Female; Humans; Infant; Male; Middle Aged; Sepsis | 1971 |
Panel discussion of the treatment of serious Gram-negative infections.
Topics: Cephalosporins; Chronic Disease; Female; Humans; Klebsiella Infections; Male; Middle Aged; Osteomyelitis; Peritonitis; Pneumonia; Pregnancy; Pregnancy Complications, Infectious; Sepsis | 1971 |
Cephalosporin antibiotics: therapeutic dimensions and future.
Topics: Adult; Cephalosporins; Child; Endocarditis, Bacterial; Female; Humans; Infant; Infant, Newborn; Meningitis, Haemophilus; Microbial Sensitivity Tests; Pregnancy; Respiratory Tract Infections; Sepsis; Staphylococcal Infections; Surgical Wound Infection; Urinary Tract Infections | 1971 |
Allergenic factors in penicillins and cephalosporins.
Topics: Allergens; Cephalosporins; Drug Hypersensitivity; Endocarditis; Humans; Immunization; Macromolecular Substances; Penicillins; Sepsis; Skin Tests | 1968 |
A clinical trial of cephaloridine.
Topics: Adolescent; Adult; Aged; Bronchopneumonia; Cellulitis; Cephaloridine; Cephalosporins; Cholecystitis; Cystitis; Female; Humans; Middle Aged; Parotitis; Pyelonephritis; Sepsis | 1966 |